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Introduction: The current challenge in critical care medicine is improving outcomes 
of intensive care unit (ICU) survivors. Many survivors experience long-lasting physical, 
cognitive, and mental impairments. The aims of this thesis are to 1) explore the current 
literature reporting on physical function utilising the concepts of post intensive care 
syndrome and the international classification of function (ICF), and 2) describe a South 
African (SA) critically ill population admitted to a privately funded hospital. 
 
Method: A scoping review was performed to determine how physical function is 
assessed in survivors. Papers were selected based on criteria defined through an 
iterative process. The results of the scoping review informed the development of the 
primary study. The primary study aimed to describe the baseline characteristics and 
outcomes of a critically ill population admitted to a privately funded hospital in SA. The 
peripheral and respiratory muscle structure using ultrasonography (US); respiratory 
and peripheral muscle strength by manual muscle testing, hand held dynamometry 
(HHD) and maximal inspiratory pressure; respiratory muscle endurance testing; 
physical function by the Chelsea critical care physical assessment tool (CPAx) and 
Barthel Index (BI); exercise tolerance by the six-minute walk test (6MWT); and health 
related quality of life (HRQoL) using the EQ-5D was assessed at different timepoints. 
 
Results: At title level 315 papers were identified and 13 papers were included in the 
scoping review. No included papers were from developing countries. Studies reporting 
physical function as activity limitation (n=5) used performance-based measures. 
Participation restrictions (n=8) were investigated using self-report measures. 
Relationships were identified between performance-based physical function and 
factors of the neuromusculoskeletal body system and self-report physical function and 
mental health impairments. 21 participants were included in the primary study. The 
median age of the sample was 70 (IQR 59-80) years, and SAPS 3 score was 57 (IQR 
43-67). A large number of participants did not demonstrate change in peripheral 
muscle thickness, but diaphragmatic thickening fraction (DTF) was >30% at all 
timepoints. Muscle weakness was seen at hospital discharge as median HHD of the 
lower limb of ≥40% of the predicted norms. Exercise tolerance was 20.8% (SD 18.6) 
of the predicted normal values. Performance-based physical function (CPAx) was 36.3 
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(SD 6.2) at ICU discharge and  41.8 (SD 5.1) at hospital discharge. Self-reported 
physical function (BI) was 80 (IQR 71-94) and 100 (IQR 95-100) at hospital discharge 
and three months. The HRQoL domains that had the highest number of participants 
demonstrating slight to severe problems at three months were mobility (n=6 [40%]), 
usual activities (n=5 [33%]) and pain (n=7 [47%]). 
 
Conclusion: Physical function is being evaluated in ICU survivors. However, the 
number of articles reporting on physical function as both activity limitation and 
participation restriction are limited. Physical function is a complex outcome. The one-
dimensional approach reported in current literature needs attention. Critically ill 
patients admitted to a privately funded hospital were older and more severely ill than 
previously documented cohorts from the public sector in SA. Exercise tolerance and 
muscle strength, were decreased at hospital discharge when compared to reference 





Inleiding: Die huidige uitdaging in kritiekesorg medisyne is om die uitkomste van 
intensiewe sorgeenheid (ISE) oorlewendes te verbeter. Baie oorlewendes ervaar 
langdurige liggaamlike, kognitiewe en geestelike beperkings. Die doel van hierdie 
tesis is om 1) die huidige literatuur oor fisiesies funksie te ondersoek deur gebruik te 
maak van die konsepte van post-intensiewe sorg sindroom en die internasionale 
klassifikasie van funksie (ICF), en 2) 'n Suid-Afrikaanse (SA) kritiek-siek bevolking te 
beskryf wat toegelaat is tot 'n privaat gefinansierde hospitaal. 
 
Metode: 'n Omvangsbepaling is uitgevoer om vas te stel hoe fisiese funksie by 
oorlewendes geassesseer word. Artikels is gekies op grond van kriteria bepaal deur 
'n iteratiewe proses. Die resultate van die omvangsbepaling het die ontwikkeling van 
die primêre studie beïnvloed. Die primêre studie het ten doel gehad om die basiese 
eienskappe en uitkomste van 'n kritiek-siek bevolking wat in 'n privaat hospitaal in SA 
opgeneem is, te beskryf. Die perifere en respiratoriese spierstruktuur deur 
ultrasonografie (VS); respiratoriese en perifere spierkrag deur manuele spiertoetsing, 
hand toestel dinamometrie (HHD) en maksimale inspiratoriese druk; uithouvermoë 
van respiratoriese spiere; fisiese funksie deur die Chelsea fisiese assessering vir 
kritieke sorg (CPAx) en Barthel Indeks (BI); oefening-uithouvermoë deur die ses 
minute stap toets (6MWT); en gesondheidsverwante lewenskwaliteit (HRQoL) met 
behulp van die EQ-5D is op verskillende tydspunte geassesseer. 
 
Resultate: Op titelvlak is 315 artikels geïdentifiseer en 13 is artikels ingesluit by die 
bestekopname. Geen artikels was van ontwikkelende lande nie. Studies wat fisiese 
funksie as aktiwiteitsbeperking rapporteer (n = 5), het prestasiegebaseerde 
maatstawwe gebruik. Deelnamebeperkings (n = 8) is ondersoek met behulp van 
selfgeraporteerde maatstawwe. Verwantskappe is geïdentifiseer tussen 
prestasiegebaseerde fisiese funksie en faktore van die neuromuskuloskeletale 
liggaamstelsel en geestes siektes en selfgeraporteerde fisiese funksie. 21 deelnemers 
is in die primêre studie ingesluit. Die mediaan ouderdom van die groep was 70 (IQR 
59-80) jaar, en die SAPS 3-telling was 57 (IQR 43-67). 'n Groot aantal deelnemers het 
geen verandering in perifere spierdikte getoon nie, maar die diafragmatiese 
verdikkingsfraksie (DTF) was te alle tye >30%. Spierswakheid is gesien tydens 
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hospitaal ontslag as 'n mediaan HHD van die onderste ledemaat ≥40% van die 
voorspelde norme. Oefening-uithouvermoë was 20,8% (SD 18,6) van die voorspelde 
norme. Prestasiegebaseerde fisieke funksie (CPAx) was 36.3 (SD 6.2) met ISE 
ontslag en  41.8 (SD 5.1) met hospitaal ontslag. Selfgerapporteerde fisiese funksie 
(BI) was mediaan 80 (IQR 71-94) en 100 (IQR 95-100) by ontslag vanaf hospitaal en 
drie maande. Die HRQoL-domeine wat na drie maande die meeste deelnemers gehad 
het wat effens tot ernstige probleme gedemonstreet het, is mobiliteit (n = 6 [40%]), 
gewone aktiwiteite (n = 5 [33%]) en pyn (n = 7 [47%]). 
 
Gevolgtrekking: Fisiese funksie word geëvalueer by ISE-oorlewendes. Die aantal 
artikels wat oor fisieke funksies verslag doen as beide aktiwiteitsbeperking en 
deelnamebeperkings is beperk. Fisiese funksie is 'n ingewikkelde uitkoms. Die 
eendimensionele benadering in die huidige literatuur, moet aandag geniet. Die kritiek-
siek pasiënte, was ouer en ernstiger siek as voorheen gedokumenteerde groepe van 
die openbare sektor in SA. Oefenings-uithouvermoë en spierkrag was verlaag in 
vergelyking met verwysingswaardes. Op drie maande het die HRQoL-maatstaf 
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GLOSSARY OF TERMS: 
 
PICS:   New or worsening functional impairments in physical, 
mental or cognitive function that develop during critical 
illness and persists after hospital discharge.(1)  
 
PICS Impairment domains: Physical, cognitive or mental health impairments.(1) 
 
ICF Constructs:   Three levels of impairments in function including body 
structure and function (physiological functions of body 
systems or anatomical parts of the body) activity 
limitations (execution of a task or action) and participation 
restrictions (problems with involvement in life 
situations).(2)  
 
COMS:   Minimum collection of outcomes that should be reported 
in all studies when conducting research within a specific 
field and serves as a standard to ensure essential 
outcome assessment.(3)  
 
ICU-AW:   Muscle weakness that develops following the onset of 
critical illness, meeting specific strength-related criteria, 





LIST OF ABBREVIATIONS: 
 
6MWD: six-minute walk distance 
6MWT: six-minute walk test 
ADL’s: activities of daily living 
ALS: Alison Lupton-Smith 
ASIS:  anterior superior iliac spine 
ATS:  American Thoracic Society 
BDI-II: Beck depression inventory 
BI: Barthel Index 
CIM: critical illness myopathy 
CIP: critical illness polyneuropathy 
COMS: core outcome measure set 
COPD:  Chronic Obstructive Pulmonary Disease 
CPAx:  Chelsea critical care physical assessment tool 
CRP:  C-reactive protein 
CT:  computed tomography 
DM: Diabetes Mellitus 
DTF: diaphragm thickening fraction 
EQ-5D:  EuroQol five dimensions 
FHSQ: functional health status questionnaire 
FIM: functional independence measure 
GCS:  Glasgow coma scale 
HADS: hospital anxiety and depression scale 
HGT:  blood glucose level 
HHD: handheld dynamometry 
HRQoL: health related quality of life 
IADL Instrumental Acts of Daily Living 
ICC:  intraclass correlation coefficient 
ICF: International Classification of Function 
ICU-AW:  intensive care unit acquired weakness 
ICU:  intensive care unit 
IESR: impact of event scale reviewed 
IMS: ICU mobility scale 
Kg:  kilograms 
LOS:  length of stay 
LOV: length of ventilation 
MIP: maximal inspiratory pressure 
MRC-SS: Medical Research Council sum score 
MRI:  magnetic resonance imaging 
MRS: Modified Rankin scale 
NMBA’s:  neuromuscular blocking agents 
PdTwi:  twitch diaphragmatic pressure 
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PI: primary investigator 
PICS: Post Intensive Care Syndrome 
PRISMA_ScR Prisma Scoping Review 
PTSD: Post-traumatic Stress Disorder 
QMLT: quadriceps muscle layer thickness 
RASS: Richmond agitation and sedation scale 
RF: Rectus Femoris 
ROM:  range of motion 
SA: South Africa 
SAPS 3: Simplified Acute Physiology Score 3 
SC: Shanita Chiba 
SES: self-efficacy scale 
SF-36 PCS: 
36 item short form survey physical component 
score 
Tdi:  diaphragm muscle thickness 
US: ultrasonography/ultrasound 
VI: Vastus Intermedius 
VIDD: ventilator induced diaphragmatic dysfunction 
WCC: white cell count 




CHAPTER 1 : INTRODUCTION 
 
The current challenge in modern critical care medicine is improving the outcome of 
intensive care unit (ICU) survivors.(4) Improved mortality and increased awareness of 
morbidity has highlighted this challenge.(5) Currently, many survivors experience a 
multitude of long-lasting impairments. These include physical, cognitive, and mental 
deficits.(1,6,7) The term used to describe these new or worsening impairments, that 
develop following critical illness and persists after hospital discharge, is post intensive 
care syndrome (PICS).(1) One of the largest health challenges faced by survivors of 
critical illness is PICS (8)  
 
The long-term impairments of PICS lead to a coexisting decline in physical 
function,(9,10) health related quality of life (HRQoL),(11) and poor return to work.(12) 
Poor HRQoL has been demonstrated as long as five years post discharge (13) and 
substantial impairments in physical function, as long as two years post discharge.(14) 
The physical domains measured within HRQoL demonstrate the largest deficit, even 
up to five years post discharge.(13) This decline in physical function and HRQoL has 
been associated with persistent muscle weakness, known as ICU acquired weakness 
(ICU-AW).(14) 
 
ICU-AW is described as clinical signs of muscle weakness that develop following the 
onset of critical illness.(10) The causes, risk factors (such as environmental exposures 
of critical illness),(4) pattern, and prevalence of muscle weakness remain poorly 
understood. Environmental exposures such as increased length of stay (LOS) in ICU, 
prolonged mechanical ventilation,(5,10) and medication exposures,(4) are associated 
with poorer patient outcomes, specifically mortality rate, physical function, and a 
higher prevalence of ICU-AW.(4,5)  
 
Parry et al. (15) found that peripheral muscle mass can decrease by as much as 30% 
within 10 days of ICU stay. A period as short as 18 hours of mechanical ventilation 
has been found to cause a decrease in diaphragmatic contractile function and caused 
diaphragmatic atrophy.(16)⁠ The damaging effects of prolonged mechanical ventilation 
on the diaphragm is termed ventilator-induced diaphragmatic dysfunction (VIDD).(16) 
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Studies performed on peripheral and respiratory muscles thus demonstrate the rapid 
way muscles are affected due to critical illness and ICU related environmental 
exposures.(17–20)  
 
Declines in peripheral and respiratory muscle function have been associated with 
prolonged hospital and ICU LOS, increased rate of re-admission, and impaired 
functional status.(21) Impairments in muscle strength have also been associated with 
secondary complications such as joint contractures, pressure sores and respiratory 
complications (atelectasis, pneumonia and weaning failure).(21)  
 
Research is increasingly focused on investigating and determining survivor outcomes 
and their experiences, in an attempt to address the major health challenge of PICS.(3) 
Unfortunately, in current research, there is considerable variance in the outcomes that 
are evaluated and how they are investigated, when assessing the post discharge 
status of critical illness survivors.(3,7,22) This prevents and delays the comparison 
and synthesis of results across studies and slows advances in research and clinical 
practice guidelines.(22)  
 
A new approach to address the variance in outcome assessment, is the creation of a 
core outcome measurement set (COMS).(3,23) A minimum collection of outcomes 
that should be reported in all studies when conducting research within a specific 
field.(3,23) This serves as a standard so that crucial outcomes are assessed in the 
same way (using the same measures), within a given field. (3,23) 
 
A COMS for ICU survivors has been developed.(3) This COMS includes the following 
domains: physical function, cognitive function, mental health, muscle and/or nerve 
function, and HRQoL.(3,23) This COMS also addresses the three major impairments 
(physical, cognitive and mental), identified in PICS.(1)  
 
Context for the impairments in physical, cognitive and mental function within PICS can 
be provided using the International Classification of Function (ICF) framework.(2) The 
ICF is a known framework of function that was compiled by the World Health 
Organization (WHO) in 2002.(2) This framework defines functioning as the interaction 
between three distinct constructs: physiological assessment (i.e. body structure and 
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function), performance-based measurement (i.e. activity limitation) and lastly, 
assessment of participation (i.e. participation restriction).(2,5)  
 
Limited studies have been reported on the outcomes of the South African (SA) critically 
ill population. To the best of our knowledge no studies have been performed on the 
outcomes of peripheral and respiratory muscle structure and function, exercise 
tolerance, and HRQoL within hospital stay of a SA critically ill population. There have 
also been limited studies published that report on physical function and HRQoL 
outcomes. 
 
In SA we have a divide within our healthcare system. One part making use of public 
health care and the other making use of private health care. The public health care 
system services 84% of the SA population.(24) However, only 23.2% of public 
hospitals have ICU and/or high care facilities.(25) In comparison, 84.4% of private 
hospitals in SA have ICU and/or high care facilities. It is thought that the resources 
and management of the public and private health care sectors vary widely, along with 
the baseline characteristics of critically ill populations. Few studies have evaluated 
these characteristics and physical outcomes of the critically ill populations within SA.  
 
A study performed in a private hospital in the Gauteng province of SA, is the only one 
known to report on baseline characteristics and outcomes of muscle strength, exercise 
tolerance, and HRQoL.(26) These outcomes were reported at one- and six-months 
post discharge, physical function was the only outcome reported on within hospital 
stay.(26) 
 
Studies performed on the critically ill population within the public health care sector 
have predominantly investigated outcomes in HRQoL, with one study evaluating 
physical function in this population.(27) Nonetheless, a decreased HRQoL, particularly 
in the physical domain, was evident in a population surviving surgical ICU in SA.(28) 
Trauma survivors in Johannesburg, also showed a decrease in the physical and 
emotional HRQoL domains at six months post discharge.(29)  
 
The aims of this thesis are to 1) explore the current literature reporting on physical 
function using the concepts of PICS (1) and the classification of function by the WHO, 
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through the ICF (2) and 2) report on baseline characteristics and outcomes of a SA 
critically ill population.  
 
Following the introduction (Chapter 1) this thesis will be presented in the following five 
chapters. A scoping review on physical function and related impairments in critical 
illness survivors (Chapter 2); a methodologic description of the primary research study 
(Chapter 3); results and statistical analysis of an observational research study on the 
patient characteristics, critical illness factors and outcomes in an adult critically ill 
population of SA (Chapter 4); and a discussion, interpretation and contextualisation of 
the statistical analysis of the primary research study (Chapter 5). Chapter 6 will 
conclude the primary research study, report on its limitations and make 
recommendations for future research. Chapter 2 will be submitted to the journal of 
Critical Care Medicine as a Scoping Review. The search will be updated before 




CHAPTER 2 : LITERATURE REVIEW 
 
This chapter was prepared as a manuscript for submission to Springer Intensive 
Care Medicine under the title “Physical function and related factors in critical 
illness survivors: A Scoping review”. (ADDENDUM A) 
 
2.1 Introduction / Background 
 
As the survival rates of critically ill patients have grown,(30) so has our interest in the 
outcomes of survivors and understanding the patterns of recovery.(31) Outcomes of 
interest have grown from the short term, merely expressing mortality, to long-term 
morbidity.(5)  
 
A large focus of research has been to identify impairments, across the course of critical 
care, that contribute to the consequences of critical illness.(1) Survivors experience 
long term complications in physical function, psychiatric function and HRQoL.(4) A 
new term to describe these worsening impairments in function (physical, mental and 
cognitive) is PICS.(1) These impairments develop during critical illness and persist 
after hospital discharge.(1)  
 
PICS has been identified as one of the largest health challenges in survivors of critical 
illness.(22) This review took a particular interest in physical function as a major 
contributing factor to PICS. Substantial impairments in physical function outcomes 
have been demonstrated years after discharge.(14) Physical function has also been 
associated with various other outcomes, within PICS, such as decreased HRQoL and 
mental health impairments (increased anxiety).(32) Importantly outcomes of physical 
function and muscle weakness are related to LOS, post discharge survival and return 
home.(5)  
 
In addition, physical function has been identified as one of the core outcomes for 
assessment in the critically ill population.(3,22,33) There is however still a lot of 
uncertainty as to how and when physical function should be measured in this 
population. Frequently used measures survey an array of different limitations in 
activities of daily living (ADL’s) and exercise tolerance.(1,4,34) Another consideration 
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in the assessment of physical function is the difference between patient self-reported 
outcome measures and performance-based outcome measures, which may inform 
different facets of physical function that are not always correlated.(7) In an 
international modified Delphi consensus study, to determine core outcome 
measurement tools, no outcome measures reached consensus for the evaluation of 
physical function.(3,33) Demonstrating the complexities of measuring physical 
function outcomes and determining its assessment within this patient population.  
 
To provide context for the current literature we thus decided to conduct a scoping 
review utilising the impairment domains of PICS (1) and the constructs of the ICF 
framework, developed by the WHO,(2) to determine how physical function is 
investigated in the literature. The ICF helped to describe the intricate and multi-
dimensional concept of function,(35) across three distinct constructs: body structure 
and function, activity limitations and participation restrictions. Our work builds on other 
studies that have also utilised the ICF framework to investigate both physical function 
(5,7) and PICS (7) in the literature. 
 
The aim of this review was therefore to map the existing literature describing physical 
function in critical illness survivors within the three constructs of the ICF; how and 
when it has been reported; as well as describe impairments in mental health as it 
relates to physical function within PICS. We propose that by unpacking the physical 
function outcomes reported in ICU survivors the results from this review could assist 




A scoping review was conducted and guided by the five-stage framework published 
by Arksey and O’Malley,(17) to map current research activity in the field of physical 
function outcomes in critically ill patients. This scoping review was also reported in 






Framework stages are as follows: 
Stage 1 - Identifying the research question  
Stage 2 - Identifying relevant studies   
Stage 3 - Study selection   
Stage 4 - Charting the data    
Stage 5 - Collating, summarising and reporting the results 
 
2.2.1 Stage 1 Identifying the research question 
 
We report on physical function from two vantage points. The first vantage point was 
from the concept of PICS which is described as new or worsening impairments in 
physical, mental or cognitive function that develop during critical illness and persist 
after hospital discharge.(1) Numerous factors have been described under the physical 
impairment domain of PICS.(1,34) We report on physical function as a major 
contributing factor to the physical impairment domain described in PICS (Figure 
2.1).(1) We decided to include the impairment domain of mental health in ICU 
survivors as they relate to physical function (Figure 2.1). In an attempt to identify 
coexisting impairments in mental health and physical function within PICS.(34) 
 
Figure 2.1: Representation of physical function as a major contributing factor to Post Intensive 
Care Syndrome (PICS) 
*=factors in physical impairments identified by Needham et al. (1) •= factors in physical impairments 
identified by Yuan et al. (34) 
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The second vantage point was reporting on physical function under the ICF framework 
(Figure 2.2). Physical function was reported as the measurement (self-reported or 
performance-based) of limitations in specific activities (e.g., walking) or ADL’s within 
the ICF constructs of activity and participation. We then aimed to identify possible 
contributing factors in “body structure and function” that might cause these limitations. 
We focused on body structure and function (physiologic) factors of the 
neuromusculoskeletal and cardiopulmonary body systems.(1,5)  
 
Figure 2.2: Physical function reported on according to the International Classification of 
Function (ICF) framework 
 
We thus included the following constructs as it relates to physical function:  
Construct 1: Activity: We described the measures of specific activities used to assess 
physical function including but not limited to the six-minute walk test (6MWT). 
Construct 2: Participation: We described the measures of ADL’s used to assess 
physical function including but not limited to the instrumental acts of daily living (IADL). 
Construct 3: Body structure & function: We described factors of neuromusculoskeletal 
and cardiopulmonary body systems. 
 
In conclusion, we describe mental health impairments, neuromusculoskeletal- and 
cardiopulmonary- body systems as factors of interest which have been investigated 




Current research question: How is physical function being investigated in the 
critically ill population and do mental health impairments, neuromusculoskeletal- and 
cardiopulmonary body systems contribute to these outcomes? 
 
2.2.2 Stage 2 Identifying relevant studies  
2.2.2.1 The objectives of this review were to describe: 
• the ICU survivor populations in which physical function has been investigated; 
• the outcome measures used to assess physical function and the time frames 
reported (Construct 1 and 2); 
• factors identified in Construct 3 related to physical function in ICU survivors; 
• the outcome measures used to assess these factors; 
• coexisting factors of mental health, identified in the impairment domain of PICS, 
as it relates to physical function in ICU survivors; 
• the outcome measures used to assess factors in this impairment domain. 
 
2.2.2.2 Search strategy 
Six computerised bibliographic databases were searched by the primary investigator 
(PI), namely PubMed, Scopus, CINAHL, MEDLINE, Science Direct, and Web of 
Science from inception to September 2019. Search terms were applied with limits on 
articles in English. Database specific search strategies were developed (ADDENDUM 
B). The search strategies for each database were verified by a librarian from the 
Department of Medicine and Health Sciences at Stellenbosch University. 
 
2.2.3 Stage 3 Study Selection  
Developing the inclusion and exclusion criteria was an iterative process undertaken 
by the reviewers while interacting with the literature. Papers were included if they 
recruited adult (18 years and older), human, critically ill survivors and reported on a 
physical function measure (self-reported or performance-based) and at least one of 
the factors of interest described previously (Section 2.2.1). We excluded papers that 
enrolled neonates, paediatrics, and adolescents, as well as papers performed on 
animals or those that were not available in English. Research protocols, reviews, 
intervention studies, studies evaluating the clinimetric properties of outcome measures 




Physical function was defined as a self-report or performance-based outcome 
measure using the description from each of the included papers methodology or 
results sections. 
 
The PI and a secondary reviewer (SC) independently and systematically screened 
and evaluated all publications returned by the search strategy for relevance to the 
review, at title, abstract and full-text level. In the event of disparities on inclusion, a 
discussion to reach consensus was arranged between the two reviewers. If consensus 
was not reached within that meeting, a third reviewer (ALS) was consulted. Full-text 
papers were retrieved by accessing electronic journals. Search terms as well as a 
summary of the findings can be found in table form in ADDENDUM B. 
 
2.2.4 Stage 4 Charting the data 
The PI extracted and charted relevant data from the included papers in a customised 
Excel data capture sheet. The data included: the country of origin; year of publication; 
research design; study setting; study participant pathologies; mean or median age of 
study population; study assessment period; factors of interest identified (mental 
health, neuromusculoskeletal or cardiopulmonary); physical function outcome 
measures used and assessment period; outcome measures used to assess the 
different factors of interest. The results section of the included papers were used to 
describe statistically significant associations between factors of interest and physical 
function. 
 
2.3 Stage 5 Collating, summarising and reporting the results 
 
The total number of search hits from the selected databases included 1 074 papers. 
Duplicate papers were eliminated, and 315 papers remained (ADDENDUM C). 





Figure 2.3: Selection process flow diagram 
 
2.3.1 Description of included papers 
All studies were conducted in developed countries from three continents. The majority 
of studies (n=7 [54%]) were conducted in North America with five published in the 
United States of America (38–42) and two in Canada.(31,43) Three studies emerged 
from Europe; Greece (n=1) [8%],(44) Germany (n=1 [8%]) (45) and Denmark (n=1 
[8%]).(46) Three studies emerged from Australia.(47–49) No studies were identified 
from Africa, Asia, or South America. Most of the studies conducted were prospective 
longitudinal cohort studies (n=12 [92%]).(31,38–47,49) One other study was a cohort 











































At title level 
n=315 
At abstract level 
n=147 
At full text level 
n=68 
Total studies included in the review 
n=13 
Titles removed (n=168) 
• Not physical function and 
factor(s) (n=151) 
• Not critical illness (n=4) 
• Not primary study (n=3) 
• Intervention study (n=3) 
• Not adult patients (n=4) 
• Neurologic patients (n=1) 
• Non-human (n=2) 
 
Abstracts removed (n=79) 
• Not physical function 
and factor(s) (n=22) 
• Not primary study 
(n=17) 
• Intervention study 
(n=25) 
• Outcome measure 
study (n=15) 
Full-text studies removed 
(n=55) 
• Not available in English 
(n=1) 
• Not physical function 
and factor(s) (n= 31) 
• Not critical illness (n=1) 







2.3.2 Year of publication 
Figure 2.4 shows the number of studies published per year. The first papers describing 
physical function linked to a factor of interest were published in 2011. Three papers 
were published in 2019. 
 
 
Figure 2.4: Number of studies published per year 
 
2.3.3 Population 
The demographics of the populations included in this review are summarised in Table 
2.1. The majority of studies included data from mixed units (n=7 [54%]) and a variety 
of primary diagnosis. The majority of studies (n=11 [85%]) included data from male 
dominant cohorts and participants aged between 40 and 60 years (n=11 [85%]).
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Table 2.1: Included papers study settings and baseline characteristics. 
 















Trauma Other NR   
Hayes et al. 
(47)  
 
   
        49.3 
(SD14.4) 
44 
Bienvenu et al. 
(38)  
 
   
        49 (SD14) 56 
Bienvenu et al. 
(39) 
 
   
        49 (SD14) 56 
Hamilton et al. 
(43) 
 
   
        56 (IQR 
45-65) 
58 
Herridge et al. 
(31)  
 
   




Sidiras et al. 
(44) 
 
   











        46 (NR) 77 
Fan et al. (40) 
   
         52 (IQR 
42-63) 
56 
Pfoh et al. (41) 
   
         49 (IQR 
41-58) 
55 
Estrup et al. 
(46) 
   
         72 (SD10) 59 





        37 (IQR 
28-55) 
83 
Aitken et al. 
(48) 
 
   
        57 (NR) 70 
Needham et 
al. (42) 
   
         48 (15) 49 
=Yes, ICU= Intensive Care Unit; NR=Not reported; ARDS=Adult Respiratory Distress Syndrome; ALI=Acute Lung Injury. 
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2.3.4 Vantage point one 
2.3.4.1 Physical function reported in relation to Construct 1 of the ICF 
Five of the included studies reported on physical function within Construct 1 of the 
ICF, activity limitation. Various specific activities were assessed using a number of 
different outcome measures. Three of the included studies evaluated walking using 
the six-minute walk test (6MWT). (40,42,48) Two of these studies evaluated physical 
function by means of the 6MWT at each of the following time points: on or before 6 
months (40,48), on or before 12 months (40,42) and between one to three 
years.(40,42) One study assessed various mobility specific activities using the ICU 
mobility scale (IMS).(47) These activities include sitting, standing, walking and 
transferring to a chair. Hayes et al. (47) performed their assessments on day 1 and 
day 20 in hospital but did not report whether these time frames were during ICU or 
ward stay. The last study used the Chelsea Physical Assessment tool (CPAx) to 
assess various specific activities.(46) These activities include coughing, respiratory 
function, grip strength, moving in the bed, transferring to a chair, sitting, sit to stand 
and stepping. The CPAx outcome measure was used at ICU discharge and three 
months. All three different outcome measures used to assess activity limitations were 
performance-based assessment measures.  
 
2.3.4.2 Physical function reported in relation to Construct 2 of the ICF 
A number of studies (n=8 [62%]) reported on physical function within Construct 2 of 
the ICF, participation restriction.(31,38,39,43–45,49) Four different outcome 
measures, Instrumental activities of daily living (IADL);(38,39) functional 
independence measure (FIM);(43,44) 36 item short form survey physical component 
score (SF 36 PCS);(31,38,41,49) and functional health status questionnaire 
(FHSQ),(45) were used to assess ADL’s. These were all self-report outcome 
measures. Even though these outcome measures were described as self-report 
measures, the IADL was completed by either participants or their proxies.(38,39) 
 
Physical function assessments using outcome measures of ADL’s were performed at 
hospital discharge (44), on or before 6 months,(31,38,39,43–45,49) on or before 12 
months (31,38,39,43–45,49), between 1 to 3 years (31,38,39,41,43,45,49) and 




2.3.4.3 Physical function reported on, within the impairment domains of PICS, 
in relation to factors of mental health  
The mental health impairment domain of PICS, as it relates to physical function, was 
most frequently assessed by measures of anxiety,(38,49) depression (38,39,43,48) 
and post-traumatic stress disorder (PTSD).(38,48,49) Two studies evaluated all the 
factors as stated (38,48), two evaluated depression only (39,43) and one study 
evaluated PTSD symptoms along with various other mental health impairments.(49)  
 
Anxiety and depression were assessed by means of two different measures. Two 
studies used the hospital anxiety and depression scale (HADS) (38,39) and another 
study used the anxiety and depression stress scale (48), to assess the same 
symptoms. Depression was assessed using the Beck depression inventory (BDI-
II).(43) 
 
PTSD symptoms were also assessed using two different measures. Namely the 
impact of event scale reviewed (IESR) (38,48) and the PTSD checklist civilian 
version.(49) The other mental health impairments were assessed as follows: 
psychological distress by means of Kessler Psychological Distress Scale, illness 
perception by means of Brief Illness Perception Questionnaire, self-efficacy by means 
of the self-efficacy scale (SES) 36 and perceived social support by means of 
Multidimensional Scale of Social Support.(49) 
 
2.3.5 Vantage point 2  
2.3.5.1 Physical function reported in relation to factors of the 
neuromusculoskeletal body system (Construct 3) 
Six studies reported on factors of the neuromusculoskeletal body system as it relates 
to physical function.(40–42,44,45,47) Muscle strength,(40–42,44,47) muscle 
structure,(47) myopathy and polyneuropathy (45) were used as measures of the 
neuromusculoskeletal body system which could affect physical function.  
 
All the studies evaluating peripheral muscle strength used the medical research 
council sum score (MRC-SS) a manual muscle test.(40–42,44,45,47) One study used 
a second measure handheld dynamometry (HHD), to assess peripheral muscle 
strength.(47) Grip strength was measured with HHD (40,42,44) and maximal 
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inspiratory pressure (MIP) was used to assess respiratory muscle strength.(40,42) 
Ultrasonography (US) (47) was used to assess muscle structure and 
electrophysiological testing to identify both critical illness myopathy (CIM) and 
polyneuropathy (CIP).(45)  
 
2.3.5.2 Physical function reported in relation to factors of the cardiopulmonary 
body system (Construct 3)  
The cardiopulmonary body system was assessed using measures for exercise 
tolerance,(31,41) activity levels,(46) pulmonary function and pulmonary structure.(31) 
Two studies used the 6MWT as an assessment measure for exercise 
tolerance.(31,41) Herridge et al. (31) investigated pulmonary structure through 
computed tomography (CT), and pulmonary function by means of spirometry. Activity 
levels were evaluated using actigraphy.(46) 
 
2.3.6 Factors of interest associated with physical function outcomes 
Three of the studies assessing physical function within Construct 1 of the ICF, as 
limitations in specific activities, evaluated factors of the neuromusculoskeletal body 
system.(40,42,47) The specific activities assessed was walking using the 6MWT 
(40,42) and other mobility specific activities using the IMS.(47) (See Table 2.2) 
 
Two of these studies assessed muscle strength as a factor of the 
neuromusculoskeletal body system. A reduction in peripheral muscle strength or 
identifying ICU-AW by peripheral muscle testing was shown to have statistically 
significant associations with outcomes in physical function within Construct 1.(40,42) 
Assessments of grip and respiratory muscle strength were also associated with 
physical function outcomes in this construct.(42)  
 
Physical function assessed within Construct 2 was most frequently assessed along 
with factors of the mental health impairment domain. Four of the included studies that 
evaluated participation using measures of ADL’s also assessed factors of mental 
health.(38,39,43,49) (see Table 2.2) The mental health factor of depression 
demonstrated statistically significant associations with physical function in two of these 




Table 2.2: Factors of interest investigated in relation to physical function. 
=Yes, ** Represents significant associations with physical function. Other mental health impairments= psychological distress, illness perception, self-efficacy and perceived social 
support. PTSD= Post Traumatic Stress Disorder; IMS=ICU mobility scale; 6MWT=six-minute walk test; CPAX= Chelsea critical care physical assessment tool; IADL=Instrumental acts 
of daily living; FIM= Functional Independence Measure; FHSQ= Functional Health Status Questionnaire; SF36 PCS= SF36 physical component score. 
Author Cardiopulmonary-vascular Neuromusculoskeletal Mental Health Physical Function 






















     **              
Bienvenu 
et al. (38) 
         ** **         
Bienvenu 
et al. (39) 
        **           
Hamilton 
et al. (43) 
        **           
Herridge 
et al. (31) 
**                   
Sidiras et 
al. (44) 
    **               
Koch et 
al. (45) 
       **            
Fan et al. 
(40) 
    **               
Pfoh et al. 
(41) 
                   
Estrup et 
al. (46) 
 **                  
Aitken et 
al. (49) 
           **        
Aitken et 
al. (48) 
        ** **          
Needham 
et al. (42) 
    **               
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A summary of the identified factors of interest, in critical illness survivors, relating to 
physical function are represented in Figure 2.5. 
 
 
Figure 2.5: A representation of the identified factors of interest related to physical function 
outcomes 
• Other= psychological distress, illness perception, self-efficacy and perceived social support.  





Our review highlights the fact that underlying factors potentially related to poor physical 
function have not been fully explored to date. While physical function outcomes of ICU 
survivors have been investigated since the late 1900’s (7) and were incorporated into 
the concept of PICS in 2012,(1) this review indicates that more focused work is needed 
in this field. Physical function is a complex concept which can explain the variety of 
factors investigated in relation to physical function outcomes in the literature. However, 
it is concerning that studies included in this review took a one-dimensional approach 
in the evaluation of physical function. 
 
None of the included studies in this review investigated physical function as both 
activity limitations and restrictions in participation (ICF Construct 1 and 2) whilst still 


















































considerations for evaluating physical function have been described, within both these 
constructs of the ICF, specifically within critical care.(5) 
 
There were however studies that included measures of specific activities, the 6MWT, 
and a measure of physical function but within the description of these studies the 
6MWT was used in the assessment of exercise tolerance.(31,41) There was no clear 
link made between this specific activity assessment and the assessment of physical 
function. In these studies, physical function was assessed using a different measure, 
as described in the methods or results sections, and thus for the purposes of this 
review only described physical function as a measure of participation restrictions.  
 
Other studies again described physical function assessment as the limitations in the 
specific activity of walking using the 6MWT,(40,42,48) but did not assess physical 
function as limitations in ADL’s within the construct of participation restrictions. 
Highlighting the fact that the link between assessing physical function as both activity 
limitation and participation restriction, is not being made. 
 
It is thus clear that there is still a need to determine consensus on how to assess 
physical function in the critically ill population, and which outcome measures to use. 
Many outcome measurement tools have been considered in the evaluation of physical 
function in this population, but none have reached consensus.(3) The use of 
standardised and validated outcome measures to assess physical function are 
imperative to allow for synthesis of results across studies.(3)  
 
To address this problem, we suggest conducting physical function assessments 
through a combined approach. Using both a measure of activity and participation. Most 
likely in the form of a self-report and performance-based measure, for example the 
6MWT and FIM. This would incorporate the assessment of more aspects of this 
complex outcome. This is beneficial as it would reveal physiological outcomes and 
patient-perceived outcomes of physical function.(7) 
 
It is evident from this review that physical function is being evaluated for time frames 
long after discharge. However, research evaluating physical function and any of the 
various factors of interest for time frames both in-hospital and after discharge, are 
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lacking. In-hospital evaluation of physical function is paramount to inform clinical 
decision making, and to assist in early identification of those at risk of poor outcomes. 
Identifying those at risk could inform in-hospital intervention and post-discharge 
rehabilitation strategies. Post-discharge assessments are needed to inform long term 
outcomes and describe the course of recovery from critical illness and PICS.  
 
2.4.1 Limitations 
The development of the inclusion and exclusion criteria for this review was an iterative 
process but articles were limited to the English language. There is a possibility that 
eligible studies may have been unknowingly excluded if they were only available in 
the language of origin, as this review only included research articles already published 
in English, without the need for translation.  
 
This review only reported on the impairment domain of mental health. The impairment 
domain of cognitive function within PICS, as it related to physical function, was not 
reported. Future research is needed to investigate possible associations between the 
outcomes of physical function and cognitive impairments. 
 
2.4.2 Implications for future research 
Research on physical function and the factors of interest is needed in developing 
countries, where no such research was identified within this review. More research is 
required to evaluate numerous factors of interest and their relation to physical function, 
to try and better determine possible associations. 
 
Factors that were not as frequently evaluated and described in association to physical 
function include: respiratory muscle strength, grip strength, muscle structure, 
pulmonary structure and function, and the other mental health impairments.(49) 
 
Even though we see that physical function is being evaluated, future research is 
needed to investigate this complex outcome as both activity limitations and restrictions 
in participation. Time frames for assessment of physical function should include 
assessments both in hospital and post discharge, to allow for better evaluation of 




From the included literature the proposed research agenda is: 
• determining a baseline on physical function outcomes, within Construct 1 and 
2, of critically ill patients in a developing country (SA);  
• assessing physical function, along with factors of interest, which have been 
shown to have associations with outcomes in physical function (peripheral and 
respiratory muscle strength), to describe their possible relation to physical 
function outcomes; 
• assessing physical function along with factors of interest that require further 
investigation: muscle structure.  
 
2.4.3 Conclusion 
Physical function is being evaluated as an outcome of interest in the critically ill 
population, but the number of articles reporting on both physical function and possible 
relating factors are limited. Physical function is a complex outcome with multiple 
factors impacting these outcomes. A one-dimensional approach to assessing physical 
function is being taken within the current literature. Therefore, further investigation is 
required to assess physical function as both limitations in activity and restrictions in 
participation, and relating factors such as peripheral and respiratory muscle strength, 
pulmonary structure and function, and muscle structure.  
 








Ethical approval form 
 





CHAPTER 3 : METHODOLOGY OF PRIMARY STUDY 
 
We developed a primary study informed by the results of the scoping review. The 
primary study was developed to answer the following question: What are the outcomes 
in physical function, muscle function, and HRQoL of patients admitted to a privately 
funded hospital ICU in SA? 
 
This chapter explains the research process used to answer the research question. It 
provides information concerning the methods that were used to undertake this 
research, as well as the justification for the use of these methods and materials. This 
chapter also describes the timeline at which each outcome was assessed during the 
research process, the selection of participants, the process of data collection and data 
analysis. 
 
3.1 Project Aim 
 
To describe the baseline demographic characteristics and critical illness factors, 
physical function, muscle function, and HRQoL outcomes, up to three months post 
discharge, of patients admitted to a privately funded hospital ICU in SA. 
 
3.2 Project Objectives 
 
3.2.1 Primary Objectives: 
• To describe the demographic characteristics and critical illness factors of 
patients admitted to private hospital ICU 
• To describe the change in muscle structure and function, of peripheral and 
respiratory muscles, from ICU admission up to hospital discharge 
• To describe the exercise tolerance of patients at hospital discharge 
• To describe physical function using both “performance-based” (to assess 
limitations in specific activities) and “self-reported” (to assess restrictions in 
participation) measures at hospital discharge  
• To describe “self-reported” physical function at three months after discharge 
• To describe the health-related quality of life (HRQoL) of patients at hospital 




3.2.2 Secondary objectives: 
• To describe the return to work of patients at three months after hospital 
discharge 
• To describe the healthcare utilisation and mortality at three months after 
hospital discharge of patients admitted to a private ICU 
 
3.3 Study Design 
 
A prospective observational cohort study. This study forms part of a larger project: 
“The impact of critical illness on muscle structure, strength and physical capability” 
(Ethics Approval Number: S16/09/173A) (ADDENDUM D). 
 
3.4 Research Setting 
 
This study was conducted in a private hospital in the Western Cape Province of SA. 
This institution has three respective intensive care units: 1) Critical care unit, 2) 
Cardiology critical care unit, and 3) Cardiothoracic critical care unit. Two of the three 
units are run as closed units managed by the respective anaesthetist’s and the third 
unit is an open unit.  
 
The individual critical care units have 12 beds (Cardiology critical care unit and 
Cardiothoracic critical care unit) and 9 beds (Critical care unit) respectively. In total 
there were 33 critical care beds within this hospital. 
 
3.5 Ethical considerations 
 
HREC approval (S18/08/176) (ADDENDUM E) was granted prior to data collection. 
Permission to conduct the research study was obtained from this private hospital prior 
to data collection (ADDENDUM F). All participants, or participants next of kin, provided 




3.6 Sample  
 
We recruited adult patients over the age of 18, admitted to any of the aforementioned 
ICU’s between 1 February 2019 and 31 July 2019, who were expected to be on 
invasive mechanical ventilation for >48 hours. Participants were included within the 
first 24 hours of mechanical ventilation. Participants were excluded if they had new or 
known neuromuscular disease, spinal cord injuries or intracranial processes. 
Participants were followed up at three months after hospital discharge, this data was 
collected until 31 October 2019. 
 
3.7 Routine management of ICU patients in this institution 
 
In bed mobility was initiated by the nursing staff. Patients were turned two hourly and 
pressure care performed unless contra-indicated. Glucose control protocols were in 
place with both intravenous and intramuscular treatment options. Different protocols 
also exist for patients with diabetes mellitus (DM) and patients with other critical 
illnesses requiring glucose control. The specific sedation used was determined at the 
discretion of the anaesthetist’s or specialist in charge of the patients’ care. The 
sedation was documented as part of the medication on the bed charts and sedation 
level was documented in each of the critical care units by means of the Richmond 
Agitation and Sedation Scale (RASS). This was documented on the ICU bedside chart. 
Weaning from invasive mechanical ventilation in this setting was determined by the 
anaesthetist’s or specialist in charge of the patients care on an individual basis. 
Patients’ ventilatory modes and means were re-viewed daily and adapted as deemed 
appropriate by the anaesthetist or specialist in charge.  
 
Physiotherapy management was performed by one of three practices that consult 
within this private institution. Group A manages mostly adult neurologic conditions and 
consulted patients once a day unless otherwise indicated or prescribed by the 
anaesthetist. Group B manages mostly cardiology and cardiothoracic admissions and 
treatments occurred mostly twice daily. Group C manages orthopaedic, post-surgical 
and medical admissions and their treatment took place once a day unless otherwise 
prescribed or indicated. All physiotherapy groups administered respiratory and 
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mobility interventions as part of their treatment. In the critical care units, early mobility-
based management was performed unless contra-indicated or specified by the 
managing anaesthetist or specialist in charge. 
 
3.8 Demographic characteristics and critical illness factors: 
 
Data on demographic characteristics and critical illness factors were collected from 
the participant’s file by the PI. This included: age, gender, height, weight medical co-
morbidities, admission diagnosis and Simplified Acute Physiology Score 3 (SAPS 3), 
date of intubation and employment status.  
 
SAPS 3 was calculated and documented electronically as part of standard practice in 
this private hospital. This score is used as an indication of severity of illness within the 
ICU setting as it can predict ICU mortality.(50) Theoretically this score can range from 
0 to 217, with a higher score being indicative of more severe illness.(51) The SAPS 3 
has been found to perform similarly to the APACHE II and SAPS II.(54) The variables 
to calculate the SAPS 3 score were entered into an online platform by the ward 
administrator.  
 
The following exposure variables were selected a priori and reported for the first three 
days of ICU admission: Ventilation mode, blood results (WCC, CRP, HGT, blood pH) 
if available, average of the patients Richmond Agitation and Sedation Scale (RASS) 
for each day, and medication exposures to corticosteroids, sedation agents and 
neuromuscular blocking agents (NMBA’s).  
 
The RASS score is used as part of standard practice in this facility and this score is 
documented on the patient’s ICU bedside chart. It is used to determine level of 
sedation or consciousness within the ICU setting. The RASS score is a 10-point scale 
with levels for anxiety or agitation (+1 to +4[combative]), alert or calm state (0) and 
levels of sedation (-1 to -5) ending in unarousable (-5).(52) The RASS has also been 




Length of ventilation (LOV) and LOS in ICU was calculated, in days, by the PI from 
the data as recorded in the bedside chart at ICU discharge. The LOV was calculated 
from the time of intubation to the time of extubation by the PI. LOS in ICU was 
calculated from the day of ICU admission to the day of ICU discharge. On the day of 
hospital discharge, the total LOS was calculated, discharge destination, and mortality 
were reported. Total LOS in hospital was defined as the total amount of days spent in 
hospital from ICU admission to discharge.  
 
3.9 Description of selected outcomes  
 
The outcomes selected for measurement in this research study were identified in 1) 
the scoping review (Chapter 2), as factors of the neuromusculoskeletal- and 
cardiopulmonary body systems relating to physical function outcomes in the critically 
ill population, and 2) as part of the core domains in evaluating patient outcomes for 
ICU survivors.(3,22,23) 
 
These outcomes were categorised by: 1) the ICF as set out by the WHO (2) and 2) 
the core domains in evaluating patient outcomes of ICU survivors. (22) An attempt 
was made to look at all the constructs of function (body structure and function, activity 
limitation and participation restriction), within the ICF,(2) while still including minimum 
important domains set out in the COMS.(3) We attempted as far as possible to use 
the outcome measures for these domains that reached consensus in the COMS.(3) 




Table 3.1: ICF classification and COMS domain, outcomes selected, and outcome measures 
used. 
 
ICF construct COMS Domain Outcome Observed Outcome measure 
used  
Body structure and 
function 
Muscle function Muscle structure US peripheral & 
respiratory muscles 




Muscle endurance Respiratory muscle 
endurance 




Exercise tolerance 6MWT 
Participation 
restriction 
Physical function Physical function self- 
report measurement 
BI 
HRQoL & pain HRQoL EQ-5D 
ICF= International Classification of Function; COMS=core outcome measurement set; US= ultrasound; 
MIP= maximal inspiratory pressure; MRC-SS= Medical Research Council Sum Score; HHD= handheld 
dynamometry; CPAX= Chelsea critical care physical assessment tool; 6MWT= six-minute walk test; 
BI= Barthel Index; HRQoL= health related quality of life; EQ-5D= EuroQol five dimensions.  
 
3.10 Data collection procedure 
 
As described in Section 3.8 baseline data were collected from patient bedside chart 
and medical files by the PI. Outcome measurements as described in Table 3.1 were 
recorded using a standardised data capture sheet (ADDENDUM H). All assessments 






Figure 3.1: Timeline of outcome measures  
ICU= intensive care unit; US= ultrasound; MIP= maximal inspiratory pressure; MRC-SS= medical 
research council sum score; CPAx= Chelsea critical care physical assessment tool; HHD= hand-held 
dynamometry; 6MWT= six-minute walk test; EQ-5D= EuroQol five dimensions.  
 
3.11 Description of selected outcome measures 
 
3.11.1 Muscle structure and function  
3.11.1.1 Peripheral and respiratory muscle structure via ultrasound (US):  
The Rectus Femoris (RF) and Vastus Intermedius (VI) muscles were assessed in 
supine with the participants knee in passive extension and neutral rotation. The point 
of reference, where the transducer was placed, was perpendicular to the long axis of 
the thigh on its anterior surface, two thirds of the distance from the anterior superior 
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iliac spine (ASIS) to the superior patellar border.(54) Three pictures were taken and 
the average of the three measurements used to determine muscle thickness. Muscle 
thickness was recorded in centimetres (cm). The images taken were grey scaled and 
the gain set and standardized. Three images were analysed at each of the time points, 
and the mean pixel intensity was calculated to determine echogenicity.(15,54)  
 
The RF and VI muscle thickness were investigated as a method of detecting muscle 
atrophy and echogenicity as an indication of muscle quality.(15) These muscles were 
chosen specifically as the RF muscle has been shown to demonstrate larger changes 
in muscle thickness and VI in echogenicity.(15) 
 
Muscle structure was assessed for the first three days in ICU, at ICU and hospital 
discharge. The Samsung Medison MySonoU6 (Samsung Company, Seoul, Korea) 
with a high frequency linear array transducer was used for the collection of data with 
US. Images were analysed offline using Image J software (NHI, USA).  
 
Assessments of diaphragm thickness (tdi) were performed on the right-hand side in 
the zone of apposition as has been previously described.(58) Images of the diaphragm 
were recorded in loops of three full tidal breathing cycles (from inspiration to 
expiration). These loops were stored and the average thickness, for inspiration and 
expiration, during each of the three breaths were included in the data set along with a 
calculation for diaphragmatic thickening fraction (DTF).  
 
Measures of diaphragm thickness were included in this dataset to investigate 
diaphragmatic atrophy. Multiple studies have suggested that patients on mechanical 
ventilation experience diaphragmatic atrophy and dysfunction.(16,20,56)  
 
DTF has been shown to be indicative of weaning success (57–59) and it may be an 
indication of diaphragmatic function and respiratory workload.(60) DTF was calculated 
as follows:(57,58) 
 
(thickness at end inspiration – thickness at end expiration) 




The intra- and interrater reliability for measures of peripheral and respiratory muscle 
structure with US was determined through a pilot study (ADDENDUM I). 
 
To describe change in both peripheral and respiratory muscle structure participants 
were grouped according to their individual percentage change between day one and 
day two in ICU. The measures of each participant at day two were compared to their 
own baseline measurement on day one of ICU admission and the percentage change 
in DTF, peripheral muscle thickness, and echogenicity were calculated. Three groups 
were established. The cut-off values for these three groups were as follows: a 
decrease of more than 10% (decrease group), less than 10% increase or decrease 
(unchanged group) and more than 10% increase in measures (increase group). This 
grouping method was similar to those previously described.(61) 
 
3.11.1.2 Peripheral muscle strength:  
Peripheral muscle strength was assessed using two outcome measures. Both these 
outcome measure assessments were performed according to previously described 
guidelines.(64) Manual muscle testing was performed for the upper and lower limbs 
by means of the MRC-SS. A total score for each participant was calculated out of 60. 
A score of less than 48 has been shown to be indicative of ICU-AW.(17,63) A second 
measure of muscle strength was included as the MRC-SS has been shown to have a 
ceiling effect in identification of less severe muscle weakness.(32)  
 
Handheld dynamometry (HHD) was performed, in combination to the MRC-SS, using 
the ErgoFET2 dynamometer (Hoggan Health, USA) for the upper limb (during 
shoulder abduction) and the lower limb (during knee extension). The score was 
measured in Newtons. The percentage of the predicted normal values was calculated 
using equations as published by Bohannon (67) for both UL and LL HHD of each 
participant. 
 
To familiarise patients with the movements when using the HDD, it was first passively 
performed by the PI and the patient was then asked to perform the movement actively 
against the dynamometer. Three repeated isometric contractions were performed and 
recorded. Measures had to be within 10% of one another, if not the measurement was 
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technically not satisfactory.(62) The highest of the three measurements were included 
in the dataset.  
 
Peripheral muscle strength was performed by means of MRC-SS at ICU discharge 
and by means of both MRC-SS and HHD at hospital discharge. 
 
3.11.1.3 Respiratory muscle strength:  
To assess respiratory muscle strength patients were positioned in sitting. MIP was 
measured by use of a manometer, the POWERbreathe, KH2 (POWERbreathe 
International Ltd, UK). This was measured through a mouthpiece after a maximal 
exhalation (at residual volume). These assessments were performed according to the 
American Thoracic Society (ATS) guidelines on respiratory muscle strength 
testing.(65) Three measures were carried out and the best of the three were included. 
Measures needed to be within 10% of each other to ensure that participants’ maximal 
efforts were recorded. MIP was recorded as cmH20. This was assessed at ICU and 
hospital discharge. 
 
3.11.1.4 Respiratory muscle endurance:  
There is no current measure for respiratory muscle endurance that has been validated 
within the critically ill population. The proposed method was based on similar 
evaluation for patients with Chronic Obstructive Pulmonary Disease (COPD) during 
an inspiratory muscle training protocol.(66) This was tested by asking patients to 
breathe against a sub maximal inspiratory load provided by a flow resistive loading 
device, the POWERbreathe KH2, until task failure. The resistive load the device offers 
during the breathing cycle is determined by a calibrated spring within the device. This 
load can be calibrated to an individually set load intensity (cmH2O). The inspiratory 
load selected was 50% of each participants’ MIP. The number of breaths taken, and 
total respiratory cycle duration was recorded at hospital discharge. 
 
3.11.2 Physical function  
Physical function was assessed using two measures, the Chelsea critical care 




3.11.2.1 Performance based physical function using the CPAx: 
The CPAx is a 10-item score where a participant can score points from zero to five, 
ranging from most dependence to most independence, for an individual activity.(67) 
The 10 activities included in the CPAx are as follows: respiratory function, cough, 
moving within the bed, supine to sitting on the edge of the bed, dynamic sitting, 
standing balance, sit to stand, transferring from bed to chair, stepping and grip strength 
(predicted for age and gender on the dominant hand).(67) A total score out of 50 was 
calculated once all the activities were evaluated. The CPAx assessment was 
performed according to the published guidelines.(67) This measure was included as 
a performance-based measure of assessment in activity limitations of physical 
function. If any activity was not appropriate due to the participant’s medical condition 
it was not assessed. CPAx assessment was performed at ICU discharge. 
 
3.11.2.2 Self-report physical function using the BI: 
The BI is another form of physical function assessment which contains 10 items. This 
index asks the participant to score each item with the statement that most closely 
corresponds to their current level of ability. If the participant was unable to complete 
the BI as a self-report it was completed by a family member familiar with the patient’s 
current abilities. The items that are scored include: bowel continence, bladder 
continence, toilet use, feeding, transfers, mobility, dressing, stairs and bathing. A total 
score out of a 100 was calculated, according to the guidelines for scoring the BI,(68) 
at hospital discharge and telephonically three months after hospital discharge. A 
higher score indicating more independence and a lower score more dependence with 
ADL’s. 
 
3.11.3 Exercise tolerance  
Exercise tolerance was assessed according to the ATS guidelines for the 6MWT.(69) 
The 6MWT is a self-paced test. Patients were asked to walk as far as possible in a 
six-minute time frame, within a 30 meter clearly marked corridor, at hospital discharge. 
The distance walked in this six-minute timeframe was recorded, and the percentage 
of the predicted normal values were calculated. The reference cohort used was that 
of healthy North Africans older than 40 years.(70) The six-minute walking distance 
(6MWD) is a commonly used measure of functional exercise capacity in the critically 
ill population.  
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3.11.4 Health related quality of life (HRQoL)  
HRQoL was assessed using the EuroQol Five Dimensions (EQ-5D). Participants were 
asked to choose a statement for each of the activities that best reflects their status of 
health on the day. One being the most independent and five being the most 
dependent. The statements for each activity range as follows: no problem, slight 
problems, moderate problems, severe problems and unable to perform the activity. 
Thereafter they completed a 20cm vertical visual analogue scale from 0 to 100 to rate 
their health. This was performed at hospital discharge and telephonically at three 
months post hospital discharge. The EQ-5D was performed and the results were 
presented according to the EuroQol Research Foundation EQ-5D user guide.(71) In 
this study the EQ-5D results were presented as a health profile and according to the 
Pareto Classification of Health Change (better, worse, the same or mixed) as 
described in the EQ-5D-5L user guide.(71) 
 
3.12 Validity of outcome measures used 
 
3.12.1 Muscle structure and function 
3.12.1.1 Peripheral and respiratory muscle structure via ultrasound (US):  
Muscle thickness using ultrasonography has been validated against other imaging 
study modalities such as magnetic resonance imaging (MRI) and computed 
tomography (CT).(72) Measures of muscle thickness using US have also been 
validated against direct measurements of muscle tissue biopsies of dissected 
cadavers.(72) An intraclass correlation coefficient (ICC) of 0.97 was found for test-
retest ability of US and CT when the RF muscle was measured on two consecutive 
days by the same investigator.(73) An ICC of 0.92 was found between US and CT 
during the assessment of RF muscle diameter.(73) Thus, measurements using US or 
CT scan-based muscle mass analysis of the quadriceps muscle, specifically RF, 
appears to be equally accurate.(74) The assessment of muscle thickness measured 
at multiple sites, by means of US and muscle tissue from the same sites, that were 
dissected from cadavers produced an ICC of >0.968 (p < 0.001).(75) This 
demonstrates the validity of US when compared to other imaging modalities or even 




US has also been suggested as a method of determining peripheral muscle thickness. 
Parry et al. (14) and Puthucheary et al. (57) found a strong relationship between 
measures of muscle function and measures of muscle thickness and echogenicity 
using US. Measurement of quadriceps muscle layer thickness (QMLT) using US has 
shown excellent intra- and inter-rater reliability.(72,74) In a study done on healthy 
participants no statistically significant difference was observed between expert and 
novice results during testing of QMLT with a confidence interval of -0.067 to -0.011 
and a p-value of 0.1607.(74) 
 
US has also been used as a non-invasive, easy to use and rapidly available tool to 
assess diaphragm structure at patient’s bedside. US showed great inter-observer 
reliability regardless of the expertise level of the tester when assessing the diaphragm 
and quadriceps muscles.(72) Muscle thickness and echogenicity using either trace or 
square method had an ICC of between 0.84 to 0.99.(72) More specifically the 
interobserver reliability for muscle thickness had an ICC of 0.97 for the quadriceps and 
0.86 for the diaphragm and echogenicity had an ICC of 0.90 for the quadriceps and 
0.85 for the diaphragm in the novice tester group.(72) 
 
3.12.1.2 Peripheral muscle strength: 
One of the most widely used methods to assess muscle strength is manual muscle 
testing by means of the Medical Research Council sum score (MRC-SS). These 
manual muscle strength assessments are done in standardized positions to ensure 
the test is reproduced in the same way. The MRC-SS has been shown to have 
excellent interrater reliability, with an ICC of 0.99 (95% CI).(17) However, the MRC-
SS has limitations in detecting less severe muscle weakness and thus has a ceiling 
effect (32) seeing as when MRC-SS scores ranging from 0 (paralysis) - 5 (normal 
muscle strength) are greater than a grade 3 (movement against gravity), the MRC-SS 
loses much of its ability to distinguish between grades of strength.(62) 
 
A more sensitive method of muscle strength testing, especially at grades 4 – 5, is 
isometric muscle strength testing using HHD.(76) HHD is more sensitive than in the 
assessment of muscle strength than the MRC-SS.(32) HHD is a reliable measurement 
of muscle strength in alert critically ill patients.(76) When assessed it showed an 
interobserver agreement with an ICC of >0.90.(62) HDD can detect muscle weakness 
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where the participant is stronger (MRS-SS greater than grade 3). Thus, a combined 
method of using both MRC-SS and HDD in the assessment of peripheral muscle 
strength was chosen in this study. This allowed for better detection of muscle 
weakness even in stronger ICU survivors. 
 
3.12.1.3 Respiratory muscle strength: 
A simple and non-invasive method of assessing respiratory muscle strength is by 
determining maximum respiratory pressures.(77) The most objective way of assessing 
respiratory muscle strength is by measuring transdiaphragmatic pressure in reaction 
to phrenic nerve stimulation (PdiTw).(78) This is however an invasive test which is 
difficult to perform. In a study to determine the correlation between MIP and PdiTw 
and thus the reliability of MIP, to assess respiratory muscle strength, the values 
between MIP and PdiTw correlated with each other (r2 = 0.373, p = <0.001).(79) In 
this study however, we have chosen to assess respiratory muscle strength by means 
of MIP as it is a safer less invasive test with minimal risk to the participant. 
 
3.12.1.4 Respiratory muscle endurance: 
There is no current measure for respiratory muscle endurance that has been validated 
within the ICU population. As previously stated, the proposed method was based on 
similar evaluation of respiratory muscle endurance for COPD patients.(66)  
 
3.12.2 Physical function 
3.12.2.1 Performance-based physical function using the CPAx: 
The Chelsea critical care physical assessment tool (CPAx) has been found to be 
reliable and valid for use in the ICU population. The CPAx demonstrated moderate to 
strong significant positive correlations with the MRC-SS, Glasgow Coma Scale (GCS), 
sedation score, peak cough flow and Australian therapy outcome measure score using 
Spearman’s rank correlation coefficient analysis.(67) This tool has been considered 
content valid with a content validity index of 1.00 (p<0.05) and had an interrater 
reliability of k 0.988 (95% CI 0.791 to 1.00; p<0.01).(80)  
 
3.12.2.2 Self-report physical function using the BI: 
In order to assess physical function at three months follow up, the Barthel Index (BI) 
was administered telephonically. In a study to determine the reliability and validity of 
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the BI administered over the phone compared to in person evaluation, the mean value 
of the BI score was 30 by telephone and 35 by in person assessment with a p-value 
of 0.29.(81) Demonstrating that telephonic administration of the BI is reliable in 
comparison within person evaluation.(81) When evaluating the validity of the BI in 
relation to the FIM and Modified Rankin Scale (MRS), in stroke patients, the correlation 
coefficients were 0.9479 (p<0.0001) between BI and FIM score and -0.8856 
(p<0.0001) between BI and MRS.(82) Showing that the three measures are highly 
correlated. 
 
3.12.3 Exercise tolerance 
The six-minute walking distance (6MWD) is a commonly used measure of exercise 
tolerance in the critically ill population. The 6MWD has been shown to have moderate 
to strong correlations to physical health measures and good convergent and 
discriminant validity.(83) 
 
3.12.4 Health related quality of life (HRQoL) 
The EQ-5D was chosen for two main reasons: 1) it is available in numerous languages 
with cultural variations and 2) it addresses multiple domains and factors that could 
potentially influence long term HRQoL. The EQ-5D was the outcome measure 
included in the core outcome measurement set, for the HRQoL domain.(3) This 
outcome measure is also one of the most used tools to measure HRQoL in the critically 
ill population.(84) The EQ-5D has been proven to have construct validity,(84) criterion 
validity and reliability.(85) 
 
3.13 Data and Statistical Analysis 
 
All data was captured electronically via Redcap secure web application (86) by the PI. 
All data collected was de-identified. Each participant was given a number by which 
their data was stored and accumulated. Only the PI had full access to the data set. 
The web application was password protected and further access to the data was 




IBM SPSS (IBM, USA) version 25 was used to analyse data. Data was tested for 
normality using the Shapiro-Wilk W-test. Means and standard deviations or medians 
and interquartile ranges was determined as appropriate for the distribution and used 
for descriptive purposes.  
 
Preliminary data analysis was done in consultation with a statistician at the 
Biostatistics Unit, Division of Epidemiology and Biostatistics, Stellenbosch University. 
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CHAPTER 4 : RESULTS OF PRIMARY STUDY  
 
In this chapter the results of the primary research study are presented with reference 
to the study aim. 
 
4.1 Participant flow 
In total 91 patients were screened and 21 were enrolled in the study between February 
and July 2019. Of the included participants five died during ICU. After ICU discharge 
one participant absconded from hospital care and was only available for follow up of 
self-reported physical function and HRQoL assessments. In total 15 participants were 






Figure 4.1: Flow diagram demonstrating participant inclusion  































Total number of 
participants screened 
for inclusion (n=91) 
Participants excluded (n=71) 
•  Patient or next of kin did 
not consent (n=6) 
•  Not assessed within 24h 
(n=2) 
•  New or known 
neurologic 
condition (n=16) 
•  Not ventilated >48 h 
(n=30) 
Participants included in 
hospital (n=21) 
Participants deceased 




up at ICU Discharge 
(n=16) 
 
Participants eligible for 
follow up at Hospital 
discharge (n=16) 
Participants followed 
up at 3 months (n=15) 
Participant(s) 
deceased before 3-
month follow up (n=1) 
Participants eligible for 











4.2 Description of population 
 
4.2.1 Demographic characteristics 
Demographic characteristics are presented in Table 4.1. The median age of the 
participants was 70 (IQR 59-80) years and 11 (52%), of the included participants 
(n=21), were male. The majority of patients were retired (n=13 [62%]), admitted for 
medical conditions (n=12 [57%]) and had known diagnosis of hypertension (n=16 
[76%]). 
 
Table 4.1: Demographic characteristics of included participants (n=21) 
 
Characteristic No. %, Unless Otherwise Specified 
Age, yr median (IQR) 70 (59-80) 
Male 11 (52) 
Weight, kg mean (SD) 89 (23) 
Height, cm mean (SD) 168 (11) 
ETOH  10 (48) 
Smoking history 8 (38) 
Current  7 (33) 
Previous 1 (5) 
Employment status   
Employed 7 (33) 
Unemployed 1 (5) 
Retired 13 (62) 
Admission diagnosis  
Medical 12 (57) 
Surgical 9 (43) 
Co-morbidities  
Hypertension 16 (76) 
Cholesterol 7 (33) 
Diabetes 8 (38) 
COPD 2 (10) 
Asthma 3 (14) 
IHD 2 (10) 
CCF 1 (5) 
RA 0 (0) 
Past TB 0 (0) 
Other 9 (43) 
− CA Colon 1 (5) 
− Chronic renal failure 1 (5) 
− Gout 1 (5) 
− Depression and anxiety 1 (5) 
− CA Abdomen 1 (5) 
− Immunosuppressed  1 (5) 
− Depression 1 (5) 
− Atrial Fibrillation 1 (5) 
− RVD + 1 (5) 
COPD= chronic obstructive pulmonary disease; IHD= ischemic heart disease; CCF= congestive cardiac 





4.2.2 Critical illness factors  
The individual severity of illness scores, LOV, LOS and mortality are shown in Table 
4.2. 
 
The median SAPS 3 score was 57 (IQR 43-67). With eight participants scoring 
between 40-50 and the majority of participants (n=13 [81%]) scoring above 53 on the 
SAPS 3. The median LOV was 6 days (IQR 3-10), ICU LOS 13 (IQR 9.5-22) days and 
total LOS in hospital 19 (IQR 15-26) days. The longest LOS was 37 days in ICU and 




Table 4.2: Severity of illness, LOV, LOS and mortality of included participants (n=21) 
 












a 40 3 9 20   
b 61 7 13 15   
c 66 6 17 17    
d 45 2 2 3    
e 71 1 3 3    
f 57 4 12 25   
g 67 8 11 19   
h 64 31 31 38   
i 81 14 17 20   
j 40 10 10 10    
k 73 5 9 19   
l 85 24 28 40   
m 28 2 37 47   
n 66 6 20 26   
o 44 4 13 16   
p 54 8 8 9    
q 32 5 11 15   
r 55 8 24 26    
s 41 11 30 35   
t 58 9 15 18   
u 48 2 12 19   
SAPS 3= Simplified Acute Physiology Score 3; LOV= length of ventilation; ICU= intensive care unit; 
LOS= length of stay.  
 
During the first three days of ICU admission the majority of participants received 
sedation agents (see Table 4.3) and were under deep sedation according to the 
Richmond agitation and sedation scale (RASS) (Figure 4.2). 
 







NMBA’s no. (%) 
Glucose control 
no. (%) 
Day 1 (n=21) 21 (100) 6 (29) 2 (10) 12 (57) 
Day 2 (n=21) 21 (100) 6 (29) 0 (0) 11 (52) 
Day 3 (n=19) 18 (94) 5 (26) 0 (0) 8 (42) 
ICU= intensive care unit; NMBA’s= Neuromuscular Blocking Agents. 
 
The level of sedation decreased within the first three days of ICU stay and by day three 
one participant did not receive any sedation. Exposures to medication for the first three 





Figure 4.2: Sedation Levels of participants 
RASS= Richmond agitation and sedation scale. 
 
4.2.3 Return to work 
Only two (40%) of the survivors who were previously employed (n=5) returned to work 
within three months after hospital discharge (see Table 4.4). Both these participants 
reported that they returned to the same type of work they were performing prior to ICU 
admission. 
 
4.2.4 Healthcare utilisation 
Half of the ICU survivors (n=8 [50%]) were discharged home and just less than half 
were discharged to a rehabilitation centre (n=7 [44%]). Of the survivors, 8 (50%) 
received physical rehabilitation after discharge from hospital and 6 (38%) were re-
admitted to hospital care. Individual healthcare utilisation is represented in Table 4.4. 
 
4.2.5 Mortality 
Mortality in hospital (n=5 [24%]) were all within ICU stay. One participant died prior to 

























Day 1 Day 2 Day 3
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a Home Retired     
b Home Employed      




Retired     
h Home Employed    








Retired     




Retired      




Retired    












Retired      
ICU=intensive care unit. 
 
4.3 Muscle structure and function 
 
4.3.1 Peripheral muscle structure: 
The median scores for RF and VI muscle thickness and echogenicity are shown in   
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Table 4.5. Median RF and VI echogenicity did seem to increase for the first three days 





Table 4.5: Measures of peripheral muscle structure  
 





Day 1 0,77 (0,64-0,82) 0,63 (0,54-0,77) 6,56 (4,25-10,14) 2,50 (1,51-5,42) 
Day 2 0,75 (0,64-0,83) 0,65 (0,54-0,70) 6,55 (3,43-8,92) 3,63 (1,63-6,84) 
Day 3 0,85 (0,69-0,93) 0,74 (0,52-0,80) 7,23 (5,13-8,79) 4,59 (1,84-5,64) 
ICU DC 0,79 (0,65-0,94) 0,67 (0,58-0,76) 7,42 (5,73-10,54) 3,68 (2,56-6,19) 
Hosp DC 0,77 (0,64-0,91) 0,68 (0,59-0,77) 6,67 (5,83-8,90) 3,05 (2,35-9,23) 
Measures presented as Median (IQR). RF=Rectus Femoris; VI=Vastus Intermedius; ICU=intensive 
care unit, DC= discharge, Hosp= hospital. 
 
Figure 4.3 represents each individual participant’s peripheral muscle thickness 
measures, for both RF and VI, between assessment time points. Between day 1 and 
day 2 in ICU, 6 (29%) participants demonstrated an increase of more than 10% in RF 
muscle thickness and 4 (19%) participants demonstrated a decrease of more than 
10% (Figure 4.3). An increase in VI thickness was seen in 7 (33%) participants and a 
decrease in 8 (38%) participants. Muscle thickness remained unchanged in the RF of 
11 (52%) participants and 6 (29%) participants in the VI. The median increase in RF 
muscle thickness was 22% (IQR 15-37) and the median decrease was 25% (IQR 13-
34). The average increase in VI muscle thickness was 17% (IQR 12-65) and the 
average decrease was 20% (IQR 15-28). 
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Figure 4.3: Peripheral muscle thickness by time point of assessment  
This figure represents individual participant data in a panel tabulation format. 1 participant per panel. For each participant, the y-axis represents muscle thickness; and the 
x-axis is the time point of assessment. 1=Day 1 in the intensive care unit (ICU), 2=Day 2 in ICU, 3=Day 3 in ICU, 4= ICU discharge, 5= hospital. The individual panels 
highlighted in red represent participants who had an increase in muscle thickness between day 1 and day 2 in ICU, whereas the panels highlighted in blue represent 







































Time point of assessment Time point of assessment 
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Figure 4.4 represents each individual participant’s peripheral muscle echogenicity, for 
both RF and VI, measures between assessment time points. Between day 1 and day 
2 of ICU admission, 7 (33%) participants demonstrated an increase of more than 10% 
in RF muscle echogenicity and 11 (52%) participants demonstrated a decrease of 
more than 10% (Figure 4.4). An increase in VI echogenicity was seen in 12 (57%) of 
participants and a decrease in 7 (33%) participants. Muscle echogenicity remained 
unchanged in the RF of 3 (14%) and 2 (10%) in the VI. The median increase in RF 
muscle echogenicity was 73% (IQR 26-130) and the average decrease was 51% (IQR 
29-65). The average increase in VI muscle echogenicity was 80% (IQR 36-139) and 




































































Time point of assessment Time point of assessment 
Figure 4.4: Peripheral muscle echogenicity by time point of assessment  
This figure represents individual participant data in a panel tabulation format. 1 participant per panel. For each participant, the y-axis represents muscle echogenicity; and 
the x-axis is the time point of assessment. 1=Day 1 in the intensive care unit (ICU), 2=Day 2 in ICU, 3=Day 3 in ICU, 4= ICU discharge, 5= hospital. The individual panels 
highlighted in red represent participants who had an increase in muscle echogenicity (worsening) between day 1 and day 2 in ICU, whereas the panels highlighted in blue 




4.3.2 Peripheral muscle function: 
Individual participant peripheral muscle function scores are represented in Table 4.6. 
 
Median MRC-SS score at ICU discharge was 53 (IQR 42 – 56) and 55 (IQR 41 – 58) 
at hospital discharge. Of the survivors (n=16), 6 (38%) demonstrated ICU-AW at ICU 
discharge. Of the participants with ICU-AW (n=6), 4 (67%) still demonstrated ICU-AW 
at hospital discharge.  
 
The median HHD score for the dominant lower limb was 40% (IQR 33 – 50), of the 
predicted for age, sex and weight related norms, and 37% (IQR 33 – 45) on the non-
dominant lower limb. The median HHD percentage predicted was 57% (IQR 42 – 66) 
on the dominant upper limb and 52% (IQR 40 – 74) on the non-dominant upper limb. 
Only 4 participants scored above 50% of the predicted normal values for their 
dominant lower limb and 10 for their dominant upper limb at hospital discharge.
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Table 4.6: Peripheral and Respiratory muscle function 
**= intensive care unit acquired weakness; MIP= maximal inspiratory pressure; MRC-SS= medical research council sum score; HHD= handheld dynamometry; 
LL= lower limb; UL=upper limb; ICU= intensive care unit; Hosp= hospital; D/C= discharge; Dom=dominance; Non-dom=non-dominance. We were unable to 
assess peripheral muscle strength, by means of MRC-SS and HHD, or respiratory muscle strength and endurance for the participant that absconded from 




Respiratory endurance  Peripheral muscle strength 
 MIP (cmH2O)  MRC-SS (/60) HHD LL (% predicted) HHD UL (% predicted) 
 ICU D/C Hosp D/C Hosp D/C ICU D/C Hosp D/C Hosp D/C Hosp D/C 
   Seconds Breaths   Dom Non-dom Dom Non-dom 
a 113 106 52 10 52 59 96 90,2 66,1 87,5 
b 61    57      
c 41 43 104 13 55 58 30,9 34,2 69,1 93,3 
d 42 33 86 11 **46 55 34,5 34,3 68,3 62,6 
e 61 66 52 23 50 51 44,6 42,9 55,5 58,4 
f 18 25 63  16 **40 **40 76,8 81,4 68,5 74,1 
g 34 51 58 23 54 56 54,1 44,5  50,6 
h 19 30 49  23 **34 **40 30,5 29 37,9 31,2 
i 47 50 49 16 56 58 29 30,5 42,4 37,9 
j 18 25 55  14 **36 **38 39,6 41,6 58,5 45,5 
k 23 26 83  19 56 53 39,7 31,5 55,6 38,6 
l 34 39 89 14 **46 53 25 25,8 36,5 39,7 
m 40 50 55  14 56 58 42,2 37 65,2 78,4 
n 13 27 27 8 **37 **41 35,3 34,2 48,1 52,2 
o 29 52 86  20 54 56 50,2 45,9 36,7 42,6 
p 37 48 35 9 56 56 49,4 53,5 61,6 51,8 
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4.3.3 Respiratory muscle structure: 
The median scores for diaphragm muscle thickness (inspiration and expiration) and 
Diaphragmatic Thickening Fraction (DTF) are shown in Table 4.7.  
 
Table 4.7: Measures of respiratory muscle structure  
 
Instance Diaphragm muscle thickness (cm) DTF (%) 
 Inspiration Expiration  
Day 1 (n=21) 0,25 (0,22-0,26) 0,2 (0,18-0,22) 18,71 (13,83-25,25) 
Day 2 (n=21) 0,25 (0,22-0,27) 0,22 (0,17-0,24) 19,12 (12,36-27,76) 
Day 3 (n=19) 0,26 (0,24-0,27) 0,22 (0,19-0,23) 17,89 (12,34-26,80) 
ICU DC (n=16) 0,26 (0,23-0,28) 0,22 (0,20-0,24) 16,10 (12,16-27,63) 
Hosp DC (n=15) 0,25 (0,23 - 0,27) 0,21 (0,18–0,23) 19,75 (12,45-29,47) 
DTF= diaphragmatic thickening fraction. 
 
Figure 4.5 represents each individual participant’s DTF measures between 
assessment time points. Between day 1 and day 2, 8 (38%) participants demonstrated 
an increase of more than 10% in DTF (Figure 4.5). A decrease of more than 10% in 
DTF was seen in 10 (48%) participants and in 3 (14%) participants DTF remained 
unchanged. The median increase in DTF was 90% (IQR 52-155) and the median 

































 Time point of assessment 
Figure 4.5: Diaphragmatic Thickening Fraction (DTF) by time point of assessment  
This figure represents individual participant data in a panel tabulation format. 1 participant per panel. 
For each participant, the y-axis represents DTF; and the x-axis is the time point of assessment. 1=Day 
1 in the intensive care unit (ICU), 2=Day 2 in ICU, 3=Day 3 in ICU, 4= ICU discharge, 5= hospital. The 
individual panels highlighted in red represent participants who had an increase in DTF between day 1 
– 2 in ICU, whereas the panels highlighted in blue represent participants whose DTF decreased.  
 
4.3.4 Respiratory muscle function:  
Individual measures for respiratory muscle strength and endurance are represented 
in Table 4.6.  
 
Median MIP at ICU discharge was 36 cmH2O (IQR 20 – 46) and 43 cmH2O (IQR 27 – 
51) at hospital discharge. A number of participants had MIP scores below 30cmH2O 
at ICU discharge (n=6 [38%]) and hospital discharge (n=5 [33%]). During respiratory 
endurance testing the mean time completed was 62.9 (SD 21.9) seconds and in this 





4.4 Physical function  
 
Individual physical function scores by means of CPAx and BI are represented in Table 
4.8.  
 
4.4.1 Performance based physical function using the CPAx: 
Mean CPAx score at ICU discharge was 36.3 (SD 6.2) and improved to 41.8 (SD 5.1) 
at hospital discharge. Only one participant scored the highest possible score 50/50 on 
CPAx, indicating the highest level of independence.  
 
4.4.2 Self report physical function using the BI: 
The mean BI score was 80 (IQR 71-94) at hospital discharge. Three participants 
scored the highest possible score 100/100 on the BI at hospital discharge (see Table 
4.8). At three months follow up the median score on the BI was 100 (IQR 95-100).  
 
Table 4.8: Individual scores for physical function, exercise tolerance, and HRQoL 
 
Participant Exercise tolerance Physical function HRQoL  
 6MWT CPAx BI EQ-5D 
 6MWD 
(meters) 
% predicted   Change 
 Hosp D/C ICU D/C Hosp D/C Hosp D/C 3 months 
Hosp D/C -
3 months 
a  447 69,89 46 50 100 95 Improved  
b   46  100 100 Improved  
f  117 25,75 40 47 80 100 Improved  
g  87 20,4 35 41 80 100 Improved  
h  12 2,07 34 38 75 100 Improved  
i  120 28,85 39 41 80 100 Improved  
k  120 19,44 36 43 80 100 Improved  
l  12 2,63 26 32 60 95 Improved  
m  60 11,73 35 43 95 100 Mixed 
n   30 36 35 25 Worse 
o  207 29,85 39 47 85 100 Improved  
q  105 18,67 35 43 70 100 Mixed 
r  255 34,54 45 48 100   
s   25 35 60 95 Improved  
t  60 9,27 34 41 80 100 Improved  
u  231 38,21 36 42 90 100 Improved  
HRQoL= health related quality of life; 6MWT= six-minute walk test; CPAx= Chelsea critical care physical 





4.5 Exercise tolerance  
 
Individual 6MWD and percentage of the predicted normal distance for age, sex and 
weight is presented in Table 4.8. 
 
Of the 16 survivors, at ICU discharge, only 13 completed the 6MWT. Two participants 
were unable to walk at the time of hospital discharge and thus could not perform the 
6MWT. Of the 13 participants that did complete the test only three were able to perform 
the tests a second time, as is required according to the ATS guidelines. The reasons 
for not completing the second test are stated in Figure 4.6. Of the participants who 
could perform the test the shortest distance walked in six minutes was 12 meters and 
the furthest was 447 meters. The median distance walked was 105 meters (IQR 12-
207). This was a mean of 20.8% (SD 18.6) of the predicted normal distance. Only one 
individual participant in this cohort achieved, a distance walked, more than 40% of the 




Figure 4.6: Reason for not completing 6MWT a second time 
6MWT= six-minute walk test.  
 
4.6 Health related quality of life (HRQoL)  
 
The EQ-5D for individual dimension scores, for this patient cohort, at hospital 
discharge and three months post discharge (follow up) are represented in Table 4.9. 
 
The HRQoL domains most affected (slight problems to severe problems) at hospital 




Reasons for not completing second 
6MWT
Too tired and refused Too short of breath Unable to walk
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(n=14 [88%]). The domains most affected at three months were mobility (n=6 [40%]), 
usual activities (n=5 [33%]) and pain or discomfort (n=7 [47%]). 
 
At three months post discharge one participant was still unable to walk, wash or dress, 
and perform usual activities. At three months post discharge from hospital participants 
still demonstrated decreased HRQoL.  
 
Using the description of health change, between ICU discharge and three months 
follow up, the majority of participants (n=12 [80%]) demonstrated better health status, 
two participants mixed health status, and one participant worse health status (see 
Table 4.8). The participant who died prior to three months follow up did not have a 
described change in health status.  
 
The median VAS score at hospital discharge was 60% (IQR 50-78.75) and 80% (IQR 
75-85) at three months post discharge. This demonstrates an improvement in overall 




Table 4.9: HRQoL dimension scores 
 
Dimension 
Hospital D/C no. (%) 
(n=16) 
Follow up no. (%) 
(n=15) 
Mobility 
No problems 1 (6) 9 (60) 
Slight problems 8 (50) 5 (33) 
Moderate problems 2 (13) 0 (0) 
Severe problems 2 (13) 0 (0) 
Unable to walk 3 (19) 1 (7) 
Self-care 
No problems 2 (13) 12 (80) 
Slight problems 8 (50) 2 (13) 
Moderate problems 2 (13) 0 (0) 
Severe problems 1 (6) 0 (0) 
Unable to wash or dress 3 (19) 1 (7) 
Usual Activities 
No problems 2 (13) 10 (67) 
Slight problems 6 (38) 2 (13) 
Moderate problems 1 (6) 2 (13) 
Severe problems 2 (13) 0 (0) 
Unable to do usual activities 5 (33) 1 (7) 
Pain/Discomfort 
No pain/discomfort 7 (44) 8 (53) 
Slight pain/discomfort 3 (19) 5 (33) 
Moderate pain/discomfort 3 (19) 2 (13) 
Severe pain/discomfort 2 (13) 0 (0) 
Extreme pain/discomfort 1 (6) 0 (0) 
Anxiety/Depression 
Not anxious/depressed 6 (38) 11 (73) 
Slightly anxious/depressed 7 (44) 3 (20) 
Moderately anxious/depressed 0 (0) 1 (7) 
Severely anxious/depressed 2 (13) 0 (0) 
Extremely anxious/depressed 1 (6) 0 (0) 




CHAPTER 5 : DISCUSSION 
 
In this chapter we will discuss, interpret and contextualise the results and statistical 
analysis as were reported in Chapter 4. We will be discussing the results under the 
following headings: demographic characteristics, critical illness factors and the 
following patient outcomes: peripheral and respiratory muscle structure and function, 
exercise tolerance, physical function, and health related quality of life. To our 
knowledge this is the first study to report on outcomes of muscle structure and 
function, during hospital stay and after discharge, of critical illness survivors in the 
private health care sector of SA.  
 
5.1 Demographic characteristics 
 
When comparing the demographic characteristics of the included participants, the 
patients in this cohort were older compared to that of other critically ill populations of 
SA. The age of the participants admitted to another private hospital, in the Gauteng 
province of SA, was 52 years.(26) The age of publicly admitted critically ill participants, 
however, ranged between those aged in their 30’s,(27,29) 40’s (87) and 50’s.(28) The 
median age of the participants in this cohort were thus almost 20 years older than in 
the critically ill populations previously reported on, in both the private and public health 
care sectors of South Africa. Further description of specifically privately admitted 
critically ill participants is needed to see if privately admitted populations are 
predominantly older than those admitted in the public sector.  
 
The public health sector of South Africa has fewer critical care resources and thus 
makes use of a triage system to best allocate resources.(24) The private sector ICU 
bed to total bed ratio in South Africa is 8.9% compared to 1.7% in the public sector.(24) 
We theorised that the triage system would favour younger adults as their age would 
relate to better outcomes and lower ICU mortality. 
 
The age of the included private population also accounts for the fact that the majority 
of participants were retired upon admission. As the mean age was above that of 
retirement age, of 65 years, in the South African population. In comparison 83% of 
participants were employed prior to critical illness in the Gauteng province private 
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hospital (26) and 52% in a public hospital population of the Western Cape 
province.(28) 
 
5.2 Critical illness factors 
 
Participants in this cohort were severely ill according to the SAPS 3 scores. With the 
majority of participants scoring above 53 on the SAPS 3, this being predictive of non-
survival, with a specificity of 83% and sensitivity of 75% in a SA population.(24) The 
high severity of illness scores might have been influenced by the high age and number 
of co-morbidities of the included critically ill population. Both age and comorbidities 
form part of the SAPS 3 score calculation to determine severity of illness.(51)  
 
Lower severity of illness scores were reported in other private and public critically ill 
populations of South Africa.(26–29,87) All these studies however reported severity of 
illness by means of APACHE II scores.  
 
Given that the participants in this cohort had a higher severity of illness one might 
expect longer LOV, LOS in ICU and total LOS. However, there did not seem to be a 
difference in these factors to that of another privately admitted critically ill population 
of South Africa.(26)  
 
The critical illness factors of LOV, ICU and total LOS were however higher compared 
to that of most public critically ill populations in SA.(27,28,87) There was however one 
study performed in the public health sector that reported longer LOS in ICU and 
hospital, similar to that of the two privately admitted populations.(29) The longer LOS 
reported by Schneiderman et al. (29) could be accounted for by the fact that this study 
only included trauma patients and the majority of these were polytrauma admissions. 
Polytrauma patients tend to score higher on the injury severity scale, the scale being 





5.3 Muscle structure and function 
 
5.3.1. Peripheral muscle structure and function: 
There is considerable variance to the way in which results on US measures of the 
peripheral muscles, specifically the RF and VI, are reported in the literature. Very few 
studies report on mean or median baseline measurements of thickness in these 
muscles. To our knowledge there is only one study that reported on baseline muscle 
thickness measures for the RF and VI.(15) Other reports describe change in muscle 
structure, of the RF and VI, as the percentage change over various time points(15) or 
the change between measures at two timepoints, described as increase or 
decrease.(19) 
 
The median baseline measures of RF and VI muscle thickness were less than in the 
study performed by Parry et al. (15) upon awakening. The participants in the study 
performed by Parry et al. (15) were younger and less severely ill compared to that of 
the included participants in this cohort. This could have attributed to the lower muscle 
thickness measures seen in this cohort.  
 
A decision was made to report on the percentage change in RF and VI muscles 
between day one in ICU and day two in ICU as change in muscle structure 
predominantly occurs in the early course of mechanical ventilation.(61) The median 
percentage change, for those participants who demonstrated a decrease in muscle 
structure in this cohort, was slightly lower than previously reported. (15) Parry et al. 
(15) however reported the percentage change of the entire cohort and not just a group 
of participants. For a large number of participants in this study change in RF and VI 
thickness remained unchanged.  
 
Puthucheary et al. (54) assessed echogenicity and reported no change in RF 
echogenicity over time, however, change in RF echogenicity was higher in participants 
who developed muscle necrosis than in those that did not. Parry et al. (15) reported a 
13% increase in RF echogenicity and 25% for VI, indicating worsening muscle quality 
over time. The median percentage change for the participants in the increase group 




It is important to note that the results in change of muscle structure for both the 
peripheral and respiratory muscles in this study should be interpreted with caution as 
the study might not have had adequate power to detect significant change in muscle 
structure over time, due to its small sample size. Nonetheless, without the 
establishment of baseline measures or minimal clinically important differences of 
muscle thickness or muscle echogenicity daily ultrasonography measures in the 
critically ill population might not currently be of value. 
 
Peripheral muscle weakness was evident in the majority of participants comparted to 
normative values using HHD, however did not seem to be largely affected on the MRC-
SS at hospital discharge. This is in line with literature stating a known limitation of 
manual muscle testing using the MRC-SS. The MRC-SS has a ceiling effect when 
attempting to determine less severe muscle weakness.(32) The percentage of 
predicted normal values for HHD indicates that participants still had peripheral muscle 
weakness at hospital discharge. 
 
5.3.2 Respiratory muscle structure and function: 
A cut-off DFT value of 30% has been associated with successful weaning from 
mechanical ventilation.(59) As seen in this cohort the median DTF values were far 
below this cut-off value at each time point of assessment. These scores below the cut-
off value for DTF, especially at ICU and hospital discharge, when participants were 
breathing spontaneously, is an indication of poor inhalation effort (89) and possible 
diaphragmatic dysfunction.(90) We hypothesise that measures of DTF could be 
indicative of diaphragmatic atrophy and contribute to respiratory muscle weakness.  
 
Results on change in diaphragm structure was reported similar to the methods 
described by Goligher et al. (61), 44% of participants demonstrated a decrease in DTF 
and 12% of participants demonstrated an increase in this study. Compared to 38% of 
participants who demonstrated an increase and 48% of participants who 
demonstrated a decrease in this study. It is important to note that Goligher et al. (61) 
reported change over eight days compared to the change between one and two days 
in this study. Significant change in diaphragm muscle thickness has been reported by 




During assessments of respiratory muscle strength, a large number of participants 
demonstrated respiratory muscle weakness. As a MIP of below 30cmH2O has been 
defined as an indication of global inspiratory muscle weakness.(91) This strengthens 
the hypothesis that the median DTF scores of below 30% could be linked to low 
respiratory muscle strength measures in these critically ill participants. Very few 
studies have evaluated respiratory muscle strength by means of MIP in the critically ill 
population, thus comparison to other critically ill populations is difficult. 
 
It is interesting to see that all participants who demonstrated a low MIP at both ICU 
and hospital discharge were the same participants identified with ICU-AW at both 
these time points. This might be an indication that these participants had global muscle 
weakness.  
 
There is currently no validated measure of assessing respiratory muscle endurance in 
the critically ill population. To our knowledge the outcome of assessing respiratory 
muscle function has not frequently been performed in the critically ill population. There 
are no normative values available for respiratory muscle endurance using the 
assessment method as described in Chapter 3. Previous studies have however 
calculated the fatigue resistance index (MIP final/MIP initial) to report respiratory 
muscle endurance.(18) Unfortunately, in this study we did not perform a measure for 
maximal inspiratory pressure following the respiratory muscle endurance test and did 
not calculate the fatigue resistance index. However, the mean time completed during 
endurance testing in this cohort, was just over one minute. Both the mean time 
completed for the entire cohort and individual respiratory muscle endurance scores 
were much lower than the expected 3 to 7 minutes of breathing participants should be 
able to perform against a resistance of 50 to 60% of MIP.(66) Indicating a decrease in 
respiratory muscle endurance in these critical illness survivors. A protocol for the 
assessment of respiratory muscle endurance measurement in the critically ill 





5.4 Physical function 
 
5.4.1 Performance-based physical function using the CPAx: 
The mean CPAx score at ICU discharge was similar to outcomes reported in a study 
performed in Soweto, SA.(27) The CPAx scores of participants were only slightly 
decreased at both time points and demonstrated an improvement between ICU and 
hospital discharge for all participants. The CPAx score was however still decreased 
for all but one participant at hospital discharge.  
 
In a study performed by Corner et al. (80) median CPAx scores similar to that of the 
participants in this study was indicative of a survival category of discharge home with 
community support. This community support is defined as the need for a package of 
care which could include outpatient therapy or home-based therapy.(80) In this study 
however, seven of the survivors required the need for additional in-patient physical 
rehabilitation following discharge. Thus most of the participants in this study were in 
the survival category similar to those discharged to short stay rehabilitation and not 
discharge home.(80) The utility of the CPAx in a SA population requires further 
investigation. 
 
5.4.2 Self-reported physical function using the BI: 
The self-report physical function scores on the BI were only slightly decreased at 
hospital discharge, but at three months follow up the BI scores for the majority of 
survivors were not decreased at all. These scores were based on participants’ ability 
to perform ADL’s. Future studies might want to consider using another self-report 
measure of physical function at follow up post discharge. As the BI has a known ceiling 
effect and might not have discriminated between patients scoring at the higher range 
of the index.(82,92)  
 
Given the evident respiratory and peripheral muscle weakness participants performed 
better than expected during assessments of physical function, both self-reported and 
performance-based. We hypothesise that self-report physical function might have 
been exaggerated at three months follow up explaining the high scores in this 




Future studies might find it beneficial to obtain retrospective measures of physical 
function to determine a baseline level of activity and general performance of ADL’s in 
comparison to assessing physical function after critical illness. Retrospective 
measures of physical function have been performed, using level of independence with 
ADL’s as scored by the Katz Index of ADL’s or highest level of mobility as scored with 
the IMS.(47) 
 
5.5 Exercise tolerance 
Exercise tolerance, a measure of functional exercise capacity, was reduced at hospital 
discharge. Exercise tolerance was assessed by means of the 6MWT determining 
6MWD and comparing these to predicted normal values for age and sex matched 
controls. The poor performance of participants during the 6MWT could be due to 
several contributing factors such as the evident peripheral and respiratory muscle 
weakness and decreased respiratory muscle endurance.  
 
The mean distance walked in six-minutes at hospital discharge was similar to that of 
an Australian population at ICU discharge.(93) Studies evaluating exercise tolerance 
long term have reported that the exercise capacity of survivors improve over time but 
at 12 months was still lower than the predicted normal values.(94) Participants 
followed up at three months, by Herridge et al. (94) were only able to walk 49% of the 
predicted normal values.(94). In this study we unfortunately did not re-assess exercise 
tolerance at three months. Thus, the long-term outcomes in exercise tolerance and 
performance based physical function is unknown. 
 
5.6 Health related quality of life (HRQoL) 
 
The median overall self-rated health status at hospital discharge, by means of the EQ-
5D VAS score, demonstrated a decreased HRQoL at this time point. (71) The self-
rated health status did however improve within the three months following hospital 
discharge, similar to that of privately admitted critically ill participants in Gauteng.(26) 
Van Aartsen and Van Aswegen (26) followed participants up until six months following 
hospital discharge and the overall self-rated health status seemed to further improve 
within this timeframe. Another study performed in Johannesburg South Africa in a 
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public hospital demonstrated lower self-rated health status, than that of privately 
admitted patients, at 6 months following discharge from a trauma ICU.(29) 
 
In other studies participants also had higher or near normal health related quality of 
life, after discharge from ICU, but then demonstrated a decrease in the longer term. 
Cuthbertson et al. (13) reported that the physical domain of participants’ quality of life 
returned to pre-morbid levels within 12 months from ICU discharge but then decreased 
again between 2.5 to 5 years. 
 
The HRQoL domains most affected at hospital discharge were usual activities, mobility 
and self-care. The domains most affected at three months were pain or discomfort, 
mobility and usual activities. This corresponds to domains which were affected at one 
month follow up in another SA critically ill population.(26) Interestingly these domains 
correspond to both the performance of specific activities and ADL’s, strengthening the 
hypothesis participants might have had limitations in physical function that were not 
evident by their BI scores. The domains reported to still be affected at six months post 
discharge in other SA critically ill populations were pain or discomfort, anxiety or 
depression, and usual activities.(26,29) Outcomes in the domains of pain or discomfort 
and anxiety or depression seem to remain affected in the longer term. Whether these 
domains remain affected and to what extent HRQoL is affected, in the SA population, 
in the long term requires further investigation.  
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CHAPTER 6 : CONCLUSION 
 
The objective of this chapter is to highlight the final conclusions drawn from the results, 
statistical analysis and their context as provided in Chapter 5. In this chapter we will 




Our study contributed to the very limited information on baseline demographic and 
critical illness factors available on the critically ill population of SA, specifically that of 
the private health care sector. Privately admitted critically ill participants differ in both 
the baseline characteristics and critical illness factors compared to that of publicly 
admitted critically ill patients. Private critically ill patients tend to be of an older age and 
more severely critically ill. Whether resource allocation plays a role on these specific 
factors when compared to the public sector population is unknown.  
 
The average age of participants in this population was well over that of retirement age 
in SA, in this population return to work was included as a purely descriptive outcome 
in order to describe HRQoL and build on the baseline data of other SA critically ill 
populations.  
 
The age and severity of illness of participants could account for the differences in 
muscle structure seen in this cohort, compared to those previously investigated. 
However, currently the assessment of outcomes in peripheral muscle structure do not 
seem be of value. Without the establishment of baseline measures or minimal clinically 
important differences of peripheral muscle thickness and muscle echogenicity daily 
ultrasonography measures in the critically ill population are difficult to put into context. 
Further investigation with larger sample sizes is required in the investigation of muscle 
structure within the critically ill population. 
 
For measures with established normative values, 6MWT and HHD, participants 
demonstrated largely decreased muscle strength and exercise tolerance in this cohort. 
These outcomes were not evident using manual muscle testing and measures of 
performance based or self-report physical function. Manual muscle testing did 
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however assist in identifying participants with ICU-AW. Participants with ICU-AW also 
demonstrated low respiratory muscle strength and impaired respiratory endurance.  
 
Even though, physical function of participants was not largely affected at hospital 
discharge or at three months follow up, assessments of HRQoL did reveal that 




This study had a number of limitations. The first of which is that it took place in only 
one study site, a private hospital, in SA. This limitation exists as there was limited 
monetary and research staff resources. This study does thus not represent the entirety 
of the SA critically ill population.  
 
This study included a small sample size. Thus, the reported statistical changes in 
specifically peripheral and respiratory muscle structure need to be interpreted with 
caution.  These results within a larger patient population might differ. The small sample 
size was pre-empted prior to the commencement of this study and thus no statistical 
correlations between outcomes were attempted, only descriptive statistics on the 
various patient outcomes. 
 
Another limitation is the possibility of confirmation bias as the PI collected the data and 
analysed the results. This might have led to unconscious bias during the interpretation 
of the study results. This bias was addressed to some extent by including outcome 
measures that have described protocols and performing the data analysis on 
deidentified information. This might have been avoided in totality by the use of an 
independent assessor. 
 
Lastly limitations existed in some of the chosen outcome measures used as tools 
during the assessments undertaken in this population. As stated in Chapter 3 the 
MRC-SS as a method of manual muscle strength testing has a known ceiling effect 
that could lead to less severe muscle weakness not being identified (62). This 
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particular limitation was addressed prior to study commencement by including a 
second measure of muscle strength assessment at hospital discharge.  
 
The assessment of physical function using both the BI and CPAx demonstrated 
limitations in this patient population. The BI has a known ceiling effect (92) and the 
potential for exaggeration bias. This bias exists as the BI is a measure of self-reported 
physical function. Participants could embellish their physical function as more 
significant than it actually is. At hospital discharge the BI was not the only measure 
used to assess physical function, but at three months follow up took place 
telephonically, we did not have a performance-based measure of physical function 
post discharge.  
 
The limitations of the CPAx to accurately determine patients discharge destination and 
rehabilitation needs, in a SA critically ill cohort, following discharge require further 
investigation. Future research should consider including another outcome measure of 
performance-based physical function within hospital stay. 
 
Exaggeration bias is also possible during the assessment of HRQoL using the EQ-5D. 
This could explain the high self-rated health status, via EQ-5D VAS score, at three 
months post discharge from hospital within this population. The short term of follow up 
of HRQoL measures is also a potential limitation as previous studies have reported 
decreased HRQoL at one year follow up even though short-term measures were near 
normal,(13) as is seen in this cohort. 
 
6.3 Suggestions for future research 
 
It is our suggestion that future research be continued in the field of outcomes within 
the critically ill population of South Africa. Research is needed specifically in the public 
health care sector of SA. To assist in the expansion of our knowledge on the outcomes 
of both public and private the critically ill populations in SA. This will allow for the further 
description of baseline characteristics, critical illness factors and patient outcomes 
within this field of study and confirm possible discrepancies between the critically ill 




Furthermore, future studies should aim at including larger sample sizes to allow for 
accurately powered statistical analysis and a more statistically conclusive description 
of change in muscle structure over time. Studies with larger sample sizes should also 
investigate possible correlations between patient outcomes, which has yet to be 
investigated in the SA critically ill population.  
 
It might also be beneficial when conducting research on outcomes such as physical 
function and health related quality of life to use both a self-report and performance-
based outcome measurement tool to avoid potential recollection bias. Future research 
should attempt to investigate the validity of outcome measures of specifically physical 
function and HRQoL in the SA critically ill populations.  
 
The long-term outcomes of critical illness survivors in SA are unknown and thus 
require future investigation. Further investigation and comparison to that of 
international critically ill populations. In addition, the data is needed to determine the 
burden of ICU survivorship on the SA healthcare system and identify optimal 
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data. 
• Manuscripts must be written English using standard scientific terms.  
• The research meets all applicable ethical standards. 
• The article adheres to appropriate reporting guidelines and community standards 
for full data disclosure.  
• All conflicts of interest should be clearly stated in the manuscript.  
• According to the Uniform Requirements for Manuscripts Submitted to Biomedical 
Journals, designation as an author must satisfy three conditions. The author must 
have: 
- Contributed substantially to the conception and design of the study, the acquisition 
of data, or the analysis and interpretation of the data. 
- Drafted or provided critical revision of the article. 
- Provided final approval of the version submitted for publication. 
• Authors of original papers and reviews are requested to provide the following 
information:  
- A "Take-home message" (two-sentences) which summarizes how the manuscript 
adds to current knowledge. This will appear in the final published version of the 
paper. 
- A 140-character Tweet that may appear online via the Intensive Care Medicine 
website or social media platforms. This Tweet will not form part of the print version 
of the manuscript. 
• The role of authors and contributors has recently been clarified by the ICMJE 
Back to top  
Types of Papers 
ICM is not accepting papers providing pre-clinical data (experimental, animal, in-
vitro, bench studies or studies without patients). These manuscripts should be 






Research articles must meet the following criteria: 
• The manuscript presents the results of primary scientific research 
• The results have not been published in full elsewhere 
• Analyses are performed to a high technical standard and are described in full in the 
manuscript 
• Conclusions are presented in a clear and concise manner and are supported by the 
data 
• Manuscripts must be written in English using standard scientific terms 
• The research meets all applicable ethical standards 
• The article adheres to appropriate reporting guidelines and community standards 
for full data disclosure. In general papers of studies that have been pre-registered or 
have a pre-published or approved protocol and analysis plan are prioritized 
• All conflicts of interest should be clearly stated in the manuscript 
• It is mandatory to upload the appropriate EQUATOR checklist for your study. Please 
find the appropriate checklist at EQUATOR Network 
• According to the Uniform Requirements for Manuscripts Submitted to Biomedical 
Journals, designation as an author must satisfy three conditions. Each author must 
have: 
- Contributed substantially to the conception and design of the study, the acquisition 
of data, or the analysis and interpretation of the data 
- Drafted or provided critical revision of the article 
- Provided final approval of the version submitted for publication 
• A statement detailing the role of each author in the study should be reported in an 
appropriate Authorship statement section of the manuscript in compliance with the 
ICMJE recommendations. 
• At the Editor’s discretion, authors may be asked to reduce the number of authors in 
the byline, whenever appropriate. The authors may add a study group name as an 
author in the byline and list the study group members in an appropriate footnote in 
the first page of the manuscript in order to have their names entered in PubMed as 
Collaborators. 
• In addition to the abovementioned statements an Authorship and Conflict of 
Interest form should be completed, signed by each author and uploaded with the 
manuscript. The form can be downloaded here. 
• A 250-word abstract and 3-5 keywords are required 
• Original papers must not exceed 3,000 words and should include no more than 5 
illustrations and tables. 
• Up to 50 references are permitted. If a higher number of references is needed, 
explain the reasons during the submission processes.  
• When reporting the results of a randomized controlled trial, author(s) should use 
the CONSORT statement as a guide in preparing the manuscript.  
Stellenbosch University https://scholar.sun.ac.za
 80 
• If the authors consider that their manuscript needs to be longer than 3,000 words 
or contain more figures or tables, the reasons for this should be justified in the cover 
letter to the Editor-in-Chief.  
• Supplementary information can be published in electronic supplements without 
limitation. 
• The journal considers only pre-registered trials. A statement should be reported in 
the manuscript. 
• The journal does not consider single centre retrospective studies 
• IRB/ethical committee approval and patient informed consent statements should 
be reported in the manuscript in the Materials and Methods section or in a separate 
section at the end of the manuscript 
• Authors of original papers and reviews are requested to provide the following 
information: 
- A “Take-home message” (two sentences) which summarizes how the manuscript 
adds to current knowledge. This will appear in the final published version of the 
paper. 
- A 140-character Tweet that may appear online via the Intensive Care Medicine 
website or social media platforms. This Tweet will not form part of the print version 
of the manuscript 
CONSORT-statement 
7-Day Profile Publications 
• Only high-quality manuscripts providing new findings from large prospective 
observational or interventional studies can be submitted as a 7-day profile 
publication, allowing important data to be rapidly available in the public domain  
• 7-day profile publications are initially assessed by the Editor-in-Chief and Deputy 
Editors, and those deemed suitable for this format sent to external reviewers. A 
decision will be notified to the authors within 7 working days 
. 
• Manuscripts will either be provisionally accepted, rejected or transferred to the 
standard peer review process. In the case of provisional acceptance, authors will have 
one day to address the reviewers’ comments and resubmit a revised manuscript. 
• From a manuscript preparation point of view, please comply with the instructions 
for Original Articles 
Review Articles, Systematic Reviews, Meta-Analyses 
• Review articles should only be submitted after prior consultation with the editors 
and are subject to the peer review process. The journal is primarily interested in 
receiving systematic reviews and meta-analyses that use high-quality methodology 
(pre-registered, published protocol, systematic search, selection and reporting paper) 
and address relevant clinical questions not already or completely addressed in the 
literature.  
• Review articles must not exceed 4,000 words and 75 references. Supplementary 
information can be published in electronic supplements without limitation. 
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• Proposals for review articles should be submitted as a two-page outline so that 
content can be discussed at an early stage. Review articles must include original 
tables, figures, graphs, and other didactic materials. They must provide unique 
information not available elsewhere. 
• Authorship should comply with the ICMJE recommendation for authorship and the 
role of each author should be specified in the first page of the manuscript below the 
byline. 
• At the Editor’s decision, authors may be asked to reduce the number of authors in 
the byline whenever appropriate. The authors may add a study group name as an 
author in the byline and list the study group members in an appropriate footnote in 
the first page of the manuscript in order to have their names entered in PubMed as 
Collaborators. 
• In addition to the abovementioned statements an Authorship and Conflict of 
Interest form should be completed, signed by each author and uploaded with the 
manuscript. The form can be downloaded below. 
• Authors of original papers and reviews are requested to provide the following 
information: 
- A “Take-home message” (two sentences) which summarizes how the manuscript 
adds to current knowledge. This will appear in the final published version of the 
paper. 
- A 140-character Tweet that may appear online via the Intensive Care Medicine 
website or social media platforms. This Tweet will not form part of the print version 
of the manuscript 
Two types of reviews are considered: Systematic Reviews and Meta-Analyses (or a 
combination of both). It is strongly recommended that systematic reviews and meta-
analyses comply with the PRISMA Statement, which is available 
here 
Conflict of Interest form (Download pdf, 162 kB)  
Narrative/Scoping Reviews 
Narrative/Scoping Reviews should only be submitted after prior consultation with the 
Editors and are subject to the peer-review process. They represent the state-of-the-
art in a specific field of research and are prepared by senior authors with a broad 
knowledge of the field. 
• Narrative reviews should not exceed 4,000 words and 80 references and should 
contain figures and tables 
• Authorship should not exceed 3 authors, preferably from different 
centres/countries, although some exceptions can be made by the Editors on a case 
by case basis depending on the topic 
• A statement detailing each Author’s role in the study and conflict of interest is 
mandatory for all papers 
• In addition to the abovementioned statements an Authorship and Conflict of 
Interest form should be completed, signed by each author and uploaded with the 
manuscript. The form can be downloaded below. 
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• IRB/ethical committee approval and informed consent statements are not required 
• A structured abstract is not required 
Conflict of Interest form (Download pdf, 162 kB)  
Editorials 
• Editorials are always commissioned by the Editors and comment on one or more 
articles in the same issue of the Journal. Editorials must not exceed 1,000 words and 
up to 15 references, and include a mandatory table or figure.  
• Editorials have a maximum of 3 authors  
• No abstract 
• Conflict of interest disclosure is mandatory for all papers 
• Conflict of interest disclosure is mandatory for all papers and should be 
accompanied by a form to be signed by each author. The form can be downloaded 
below. 
Letters to the Editor 
• Letters to the editor provide an opportunity to present results of high scientific 
value where a short format is most appropriate. Typically, letters are dedicated to 
small pilot/feasibility studies and/or preliminary data. They must not exceed 500 
words, 5 references and 1 figure or table. 
• The journal does not consider case reports or brief reports for publication. 
• Authorship of letters to the editor should be limited to 5 authors or less. In case of 
letters which stem from an original study with a higher number of authors, a choice 
must be made by the authors on the names that should appear in the byline and 
those that may appear in a footnote or in a study group 
• Study group collaborating authors should be included in the front page but 
separate from the byline 
• To the Editor’s discretion the authors may be asked to specify the role of each 
author in the article preparation 
From the Inside 
• From the inside includes poetry, trivia, personal stories, thoughts and memories, 
sounding boards, obituaries or other qualitative materials that authors wish to share 
with colleagues. 










Limits applied to database: 







1. ("critical illness" OR critical illness OR critical 
illness [MeSH]) AND ("physical function” OR 
physical function OR physical function [MeSH]) 
124 
2. #1 AND ("cardiopulmonary vascular" OR 
cardiopulmonary vascular OR cardiopulmonary 
vascular [MeSH]) OR (cardiopulmonary OR 
cardiopulmonary [MeSH]) OR (cardiovascular OR 
cardiovascular [MeSH]) OR (pulmonary OR 
pulmonary [MeSH]) 
12 
3. #1 AND (neuromusculoskeletal) OR 
neuromusculoskeletal [MeSH]) OR neuromuscular 
OR neuromuscular [MeSH]) 
16 
4. #1 AND psychological OR psychological [MeSH] 11 
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1. "critical illness" AND "physical function”  164 
2. #1 AND ("cardiopulmonary vascular" OR 
cardiopulmonary OR cardiovascular OR 
(pulmonary OR pulmonary) 
27 
3. #1 AND (neuromusculoskeletal OR 
neuromuscular) 
20 
4. #1 AND psychological  18 
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1. ("critical illness" AND "physical 
function") OR ("critical illness" 
AND "physical function") OR 
("critical illness" AND "physical 
function") 
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2. #1 AND ("cardiopulmonary 
vascular" OR cardiopulmonary 
OR cardiovascular OR 
pulmonary) OR AB 
("cardiopulmonary vascular" OR 
cardiopulmonary OR 
cardiovascular OR pulmonary) 
OR ("cardiopulmonary vascular" 
OR cardiopulmonary OR 
cardiovascular OR pulmonary) 
6 
3. #1 AND neuromusculoskeletal 






4. #1 AND psychological  11 
5. #2 OR #3 OR #4 26 
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3. #1 AND (neuromusculoskeletal 
OR neuromuscular)  
10 
4. #1 AND psychological OR AB 
psychological OR MW 
psychological 
6 
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Project ID: 3665 
Ethics Reference No: S16/09/173A 
Project Title: The impact of critical illness on muscle structure, strength and physical capability   
Dear Dr. Alison Lupton-Smith 
We refer to your request for an extension/annual renewal of ethics approval received 01/06/2020.
The Health Research Ethics Committee reviewed and approved the annual progress report through an expedited review process.
The approval of this project is extended for a further year.
Approval date: 10 June 2020
   Expiry date: 09 June 2021
Kindly be reminded to submit progress reports two (2) months before expiry date. 
Where to submit any documentation
Kindly note that the HREC uses an electronic ethics review management system, Infonetica, to manage ethics applications and ethics review process. To
submit any documentation to HREC, please click on the following link: https://applyethics.sun.ac.za.
Please remember to use your Project Id 3665 and ethics reference number S16/09/173A on any documents or correspondence with the HREC concerning
your research protocol. 
Yours sincerely,
 
Mrs. Melody Shana 
Coordinator: Health Research Ethics Committee 1
National Health Research Ethics Council (NHREC) Registration Number:
REC-130408-012 (HREC1)·REC-230208-010 (HREC2)
Federal Wide Assurance Number: 00001372
Office of Human Research Protections (OHRP) Institutional Review Board (IRB) Number:
IRB0005240 (HREC1)·IRB0005239 (HREC2)
 
The Health Research Ethics Committee (HREC) complies with the SA National Health Act No. 61 of 2003 as it pertains to health research. The HREC abides by the ethical
norms and principles for research, established by the World Medical Association (2013). Declaration of Helsinki: Ethical Principles for Medical Research Involving Human
Subjects; the South African Department of Health (2006).Guidelines for Good Practice in the Conduct of Clinical Trials with Human Participants in South Africa (2nd edition);
as well as the Department of Health (2015). Ethics in Health Research: Principles, Processes and Structures (2nd edition).
 
The Health Research Ethics Committee reviews research involving human subjects conducted or supported by the Department of Health and Human Services, or other federal
departments or agencies that apply the Federal Policy for the Protection of Human Subjects to such research (United States Code of Federal Regulations Title 45 Part 46);
and/or clinical investigations regulated by the Food and Drug Administration (FDA) of the Department of Health and Human Services.
Page 1 of 1
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ADDENDUM E : Ethics approval S18/08/176 
 
 




11/10/2018                                                           
Project ID : 8207 
HREC Reference #: S18/08/176   
Title: The Outcomes of Privately Admitted Intensive Care Unit Patients up to Three Months Post Discharge 
  
Dear Miss Helena Pool, 
The New Application received on  29/08/2018 15:45  was reviewed by members of Health Research Ethics Committee 2
(HREC2) via expedited review procedures on 11/10/2018  and was approved.
Please note the following information about your approved research protocol:
Protocol Approval Period: This project has approval for 12 months from the date of this letter.
Please remember to use your Project ID  [8207] on any documents or correspondence with the HREC concerning your research protocol.
Please note that the HREC has the prerogative and authority to ask further questions, seek additional information, require further modifications, or
monitor the conduct of your research and the consent process.
After Ethical Review 
Please note you can submit your progress report through the online ethics application process, available at: Links Application Form Direct
Link  and the application should be submitted to the HREC before the year has expired. Please see Forms and Instructions on our HREC website
(www.sun.ac.za/healthresearchethics) for guidance on how to submit a progress report.
The HREC will then consider the continuation of the project for a  further year (if necessary). Annually a number of projects may be selected
randomly for an external audit.
Provincial and City of Cape Town Approval
Please note that for research at a primary or secondary healthcare facility, permission must still be obtained from the relevant authorities (Western
Cape Departement of Health and/or City Health) to conduct the research as stated in the protocol. Please consult the Western Cape Government
website for access to the online Health Research Approval Process, see: https://www.westerncape.gov.za/general-publication/health-research-
approval-process. Research that will be conducted at any tertiary academic institution requires approval from the relevant hospital manager. Ethics
approval is required BEFORE approval can be obtained from these health authorities.
We wish you the best as you conduct your research.
For standard HREC forms and instructions, please visit: Forms and Instructions on our HREC
website https://applyethics.sun.ac.za/ProjectView/Index/8207  





Health Research Ethics Committee 2 (HREC2).
National Health Research Ethics Council (NHREC) Registration Number:
REC-130408-012 (HREC1)·REC-230208-010 (HREC2)







Project ID: 8207 
Ethics Reference No: S18/08/176 
Project Title: Effect of timing of source control on outcomes in acute appendicitis   
  
Dear Miss Helena Pool, 
Your request for extension/annual renewal of ethics approval dated 16/08/2019 15:26 refers.
The Health Research Ethics Committee reviewed and approved the annual progress report through an expedited review process.
The approval of this project is extended for a further year.
Approval date: 26 August 2019
Expiry date: 25 August 2020
Kindly be reminded to submit progress reports two (2) months before expiry date. 
Where to submit any documentation
Kindly note that the HREC uses an electronic ethics review management system, Infonetica, to manage ethics applications and ethics review
process. To submit any documentation to HREC, please click on the following link: https://applyethics.sun.ac.za.
Please remember to use your Project ID [8207] and ethics reference number [S18/08/176] on any documents or correspondence with the HREC
concerning your research protocol. 
Yours sincerely,
 
Mr. Francis Masiye, 
HREC Coordinator,
Health Research Ethics Committee 2 (HREC2). 
National Health Research Ethics Council (NHREC) Registration Number:
REC-130408-012 (HREC1)·REC-230208-010 (HREC2)
Federal Wide Assurance Number: 00001372
Office of Human Research Protections (OHRP) Institutional Review Board (IRB) Number:
IRB0005240 (HREC1)·IRB0005239 (HREC2)
 
The Health Research Ethics Committee (HREC) complies with the SA National Health Act No. 61 of 2003 as it pertains to health research. The
HREC abides by the ethical norms and principles for research, established by the World Medical Association (2013). Declaration of Helsinki:
Ethical Principles for Medical Research Involving Human Subjects; the South African Department of Health (2006).Guidelines for Good
Practice in the Conduct of Clinical Trials with Human Participants in South Africa (2nd edition); as well as the Department of Health
(2015). Ethics in Health Research: Principles, Processes and Structures (2nd edition).
 
The Health Research Ethics Committee reviews research involving human subjects conducted or supported by the Department of Health and
Human Services, or other federal departments or agencies that apply the Federal Policy for the Protection of Human Subjects to such research
(United States Code of Federal Regulations Title 45 Part 46); and/or clinical investigations regulated by the Food and Drug Administration
(FDA) of the Department of Health and Human Services.
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ADDENDUM G : Participant information leaflet and informed consent 
 
PARTICIPANT INFORMATION LEAFLET AND CONSENT FORM 
 
TITLE OF THE RESEARCH PROJECT: 
 





PRINCIPAL INVESTIGATOR: Miss Helanie Pool 
 
ADDRESS: Division Physiotherapy, Faculty of Interdisciplinary Health Sciences, 
University of Stellenbosch, Tygerberg Campus, Western Cape 
 
CONTACT NUMBER: 0733874888 
 
You are being invited to take part in a research project.  Please take some time to read 
the information presented here, which explains the details of this project. The study 
staff or doctor will answer any questions you may have about this project that you do 
not fully understand.  It is important that you understand what this research entails and 
how you could be involved.  Also, your participation is entirely voluntary. If you say no, 
this will not affect you in any way whatsoever.  You are also free to stop participating 
in this study at any stage, even if you do agree to take part. 
 
This study has been approved by the Health Research Ethics Committee at 
Stellenbosch University and will be conducted according to the ethical guidelines and 
principles of the international Declaration of Helsinki, South African Guidelines for 
Good Clinical Practice and the Medical Research Council (MRC) Ethical Guidelines 
for Research. 
 
What is this research study all about? 
 Aim  
This study will look at how well people that have been in hospital and connected to a 
machine that helps you breathe (ventilator), for more than one day, recover within 
three months after they leave the hospital.  
 Setting 
This study will take place at the intensive care units at Vergelegen Mediclinic (VMC). 
Critical care unit F (FICU), Cardiology critical care unit N (NICU) and Cardiothoracic 
critical care unit M (MICU). We hope to recruit 39 people to be part of the study during 
their hospital stay.  
 Procedure  
Information like your age, gender, diagnosis, date you were connected to the breathing 
machine, number of days connected to the machine, medication you received, settings 
of the breathing machine, number of days in ICU, number of days in hospital and blood 
results will be collected by the researcher.  
During your time in the ICU: We will be measuring your breathing muscle (diaphragm) 
and the main muscle on the front of your thigh (quadriceps) by using an ultrasound 
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machine. This will be done on the first three days of your stay in ICU and repeated the 
day you leave the ICU and at the time you leave the hospital.  
You will be positioned in your bed with your head up. The researcher will find your rib 
space and place the ultrasound probe with ultrasound gel in these spaces, to see the 
breathing muscle. Pictures will be taken while you breathe in and out for three breaths. 
For the thigh muscle you will be lying on your back in your bed with your knee 
completely straight. A point two thirds between your hip (pelvis) and knee cap (on your 
thigh) will be identified, where the ultrasound probe with ultrasound gel will be placed 
to see the muscle and a picture will be taken. You will not feel any pain when the 
researcher takes these pictures. 
The day you leave the ICU to the general ward the following tests will be done:  
• Breathing (respiratory) muscle strength test: You will be positioned in bed with 
your head up. You will be asked to breathe out as far as you can and then take a 
breath as deep as possible through a machine with a mouth piece. You will rest for 
two minutes, and then be asked to do this again. This will be done three times to find 
the best value of your strength. These measures are risk free, but you might feel dizzy 
after you have done the breaths. This will be tested again the day you leave the 
hospital.  
• Arm and leg muscle strength test: The researcher will ask you to resist certain 
movements of your arms and then your legs. The arm movements are: lifting your arm 
to the side and front, bending and straightening your elbow and bending and 
straightening your wrist. The leg movements are: bending and straightening your hip, 
bending and straightening your knee, and bending and straightening your ankle. The 
researcher will be positioning you comfortably for each of these assessments in a 
standard way.  
• Physical function test: To test how well you have recovered in terms of 
everyday activities we use a tool called the CPAx. The activities we test are: how you 
breathe, cough, move in the bed, go from lying on your back to sitting on the edge of 
the bed, moving while sitting, standing balance, sit to stand, moving from the bed to a 
chair, stepping and grip strength. You do not have to be able to do all of these activities 
and we will help you if we need to, you will only be asked to perform the ones you can. 
You will be given clear instructions for each activity.  
The day you leave the hospital the following test will be done: 
• Arm and leg muscle strength test: The researcher will show you how to perform 
two movements, one for your shoulder (lifting your shoulder to the side) and one for 
your knee (straightening your knee). After this has been demonstrated you will be 
asked to perform these movements against a small electronic machine. This machine 
measures how much pressure you give when doing these movements. This will be 
tested when you are discharged from the hospital. 
• Respiratory (breathing) muscle endurance: You will be sitting with your arms 
supported. The researcher will assess your breathing muscle endurance with a 
machine you place in your mouth. This machine will give resistance while you breathe 
in. You will be asked to breathe in and out through the machine for as long as you can. 
The researcher will measure how long you are able to continue breathing and how 
many breaths you take in this time.  You may feel tired or dizzy during this test, but it 
is not painful. 
• Physical function test: The Barthel Index This form asks about how much help 
you need with activities like going to the bathroom, grooming, using the toilet, eating, 
moving, dressing, climbing stairs and bathing.  
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We will be phoning you three months after you have left the hospital and you will be 
asked the same questions again. 
• Exercise tolerance (how well you can tolerate exercise): You will be wearing 
comfortable clothes and shoes and use your normal walking aids if you are using any. 
During this test we will see how far you can walk in six (6) minutes.  You can walk as 
fast as you want during the test and take as many breaks as you need.  We will ask 
you how breathless you feel before and after the test. We will also measure your heart 
rate, blood pressure and oxygen levels before, during and after the test.  
• Quality of life assessment and physical function test: We are going to ask you 
some questions about things you do in the day and what you think of your health.  We 
will ask about how easily you can move and look after yourself.  We will also ask if you 
have any pain or feel down or anxious.  We will also ask you to give your health on 
the day a mark out of 100. The second form asks about how much help you need with 
activities like going to the bathroom, using the toilet, eating, moving, dressing, climbing 
stairs and bathing.  
We will be phoning you three months after you have left the hospital and you will be 
asked the same questions again. 
 
Three months after you have left the hospital we will be phoning you:  
We will need to record your phone number so that in three (3) months’ time we can 
phone you. When we phone you, we will ask the same questions about your regular 
activities and what you think of your health. We will also ask about your need to visit 
the hospital or if you were re-admitted to the hospital in that time. We will also ask 
whether you have returned back to your normal work. 
Why have you been invited to participate? 
 People admitted to an ICU sometimes get so weak after they are discharged 
that they struggle to return to everyday activities once they are sent home. This study 
will look at this weakness. It will also tell us what happens when these people go to a 
general ward, when they are discharged from hospital and how they recover in the 
following three months once they go home. This can help us to identify people that 
have a higher risk of becoming weak while they are in ICU and help to find ways to 
improve treatment that might prevent weakness and long stays in the ICU.  
What will your responsibilities be? 
 You as participant will be asked to stay relaxed and report any pain or 
discomfort during any of the tests we perform. 
 During the ultrasound measurements you will have to lie still and breathe 
normally. When the strength measurements are done, you will be asked to stay calm 
and take the deepest possible breath you can. After this you can rest and recover. 
You will be asked to sign informed consent to take part in the study. You can stop 
taking part in this study at any time and this will not change the care you receive.  
 
Will you benefit from taking part in this research? 
 You will not benefit directly from this study, but in the future people may benefit 
from the results. These results will help future studies to identify people at high-risk to 
prevent weakness due to illness and ventilation.  
 
Are there risks involved in taking part in this research? 
 There are no risks involved in the ultrasound tests done in the ICU, the Barthel 
Index of your physical function or the quality of life test of the EQ-5D. During strength 
tests of your arms and legs, exercise tolerance, physical function using the CPAx tool 
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and the breathing muscle tests you might experience shortness of breath or feel tired. 
We will make sure there are monitors for that and oxygen for you if there are any signs 
of distress or discomfort. We will also inform a doctor if you become uncomfortable to 
ensure you are checked and taken care of. These tests are routine and are mainly 
risk-free. 
 
If you do not agree to take part, what alternatives do you have? 
 Standard care will continue as per normal, for all patients. This study does not 
involve treatment. 
 
Who will have access to your medical records? 
 All data will be kept confidential and saved on an electronic database called 
Redcap. Each participant will have a study number and only the researcher and 
research assistant will have access to personal information such as your phone 
number.  This is so that she can contact you again after three (3) months. The results 
will be published in a thesis and a publication where all the information will remain 
anonymous (no one will know the information belongs to you). Members of the Ethical 
committee may need to inspect research records for auditing purposes.  
 
What will happen in the unlikely event of some form injury occurring as a direct result 
of your taking part in this research study? 
 In the rare event of any injury occurring during this study, the team of health 
professionals in the ward will act immediately as needed. You as participant are 
covered by the insurance of the University of Stellenbosch.  
 
Will you be paid to take part in this study and are there any costs involved? 
 No you will not be paid to take part in the study and there will be no costs, if 
you do take part. 
 Participation in this study does not cover any of the costs related to your 
admission and medical management. 
 It is important to note that you (or your medical) are still responsible for the 
costs related to your healthcare and the current admission. 
 
Can we contact you for future research studies related to your hospital stay? 
Yes      No  
 
Is there anything else that you should know or do? 
 You can contact Helanie Pool on 0733874888 if you have any questions or 
encounter any problems. 
 You can contact the Health Research Ethics Committee at 021-938 9207 if you 
have any concerns or complaints that have not been helped with by your study 
researcher. 






Declaration by participant 
 
By signing below, I …………………………………..…………. agree to take part in a 
research study entitled: The outcomes of privately admitted intensive care unit patients 
up to three months post discharge. 
 
I declare that: 
 
• I have read or had this information and the consent form read to me and it is 
written in a language which I am fluent and comfortable with. 
• I have had a chance to ask questions and all my questions have been 
adequately answered. 
• I understand that taking part in this study is voluntary and I have not been 
pressured to take part. 
• I may choose to leave the study at any time and will not be penalised or 
prejudiced in any way. 
• I may be asked to leave the study before it has finished, if the study doctor or 
researcher feels it is in my best interests, or if I do not follow the study plan, as agreed 
to. 
 
Signed at (place) ......................…........…………….. on (date) …………....……….. 
2018. 
    
Signature of participant Signature of witness 
 
Declaration by investigator 
 
I (name) ……………………………………………..……… declare that: 
 
• I explained the information in this document to ………………………………….. 
• I encouraged him/her to ask questions and took adequate time to answer them. 
• I am satisfied that he/she adequately understands all aspects of the research, 
as discussed above 
• I did/did not use a interpreter.  (If an interpreter is used then the interpreter must 
sign the declaration below. 
 




    





Declaration by interpreter 
 
I (name) ……………………………………………..……… declare that: 
 
• I assisted the investigator (name) ………………………………………. to explain 
the information in this document to (name of participant) 
……………..…………………………….. using the language medium of 
Afrikaans/Xhosa. 
• We encouraged him/her to ask questions and took adequate time to answer 
them. 
• I conveyed a factually correct version of what was related to me. 
• I am satisfied that the participant fully understands the content of this informed 
consent document and has had all his/her question satisfactorily answered. 
 






























































































ADDENDUM I : Pilot Study 
 




• To determine the intra-rater reliability of ultrasonography measurements 
• To determine the inter-rater reliability of ultrasonography measurements 
• To determine the intra-rater reliability of peripheral muscle strength by handheld 
dynamometry  
• To determine the intra-rater reliability of respiratory muscle strength by 




Study setting: This pilot study was conducted in two settings. Ultrasonography 
measures were conducted in a public hospital in Cape Town, South Africa (SA). 
Peripheral and respiratory muscle strength measures were conducted in a private 
practice in Somerset West, Cape Town, SA. 
 
Ethical considerations: All participants provided informed consent 
 
Sample:  
Ultrasonography: A sample of convenience; included seven critically ill adult 
individuals for measures of diaphragm thickness and five critically ill individuals for 
measures of peripheral muscle thickness and echogenicity. 
Peripheral and respiratory muscle strength measures: A sample of convenience; 





Procedure: The Primary Investigation (PI) scheduled three meetings with the expert 
ultrasonographer (EUS). At each instance the aims and objectives for ultrasonography 
measures were explained to each participant and informed consent was obtained. At 
the third meeting, intra-rater reliability and inter-rater reliability of ultrasound 
measurements were established. Peripheral muscle thickness (RF and VI) and 
echogenicity (see Table 1 and 2) as well as diaphragm thickness for both inspiration 
and expiration (see Table 3), were measured by the PI. Measurements were 
completed in the same order by the PI. The test setting and equipment set-up 
remained standardized and all equipment was calibrated prior to testing. The 
measures for ultrasonography of the diaphragm and quadriceps were performed as 
described in Section 3.11.1.1. 
 
Intra-rater reliability: Ultrasounds measurements of the peripheral muscles and 
diaphragm were performed by the PI on the same day separated by a 30-minute 
interval, using the same ultrasound equipment with the participant in a relaxed, supine 




Inter-rater reliability: Ultrasound measurements of the peripheral muscles and 
diaphragm were performed by the EUS on the same day separated by a 30-minute 
interval, using the same ultrasound equipment with the participant in a relaxed, supine 
position. PI and EUS measurements of peripheral muscles and diaphragm thickness 
were compared to establish inter-rater reliability. 
 
Table 1: Intra-rater and inter-rater reliability of quadriceps thickness 
measurements 
RF  
US 1 US 2 US 3 EUS: 
mean 
PI 1 PI 2 PI 3 PI: mean PI: mean 
2 
1,046 1,059 1,059 1,055 1,132 1,138 1,159 1,143 1,269 
0,509 0,489 0,523 0,507 0,448 0,523 0,502 0,491 0,586 
0,325 0,325 0,346 0,332 0,36 0,34 0,34 0,347 0,333 
0,523 0,516 0,523 0,521 0,53 0,557 0,577 0,555 0,502 
0,712 0,718 0,732 0,721 0,908 0,874 0,935 0,906 1,272 
VI  
0,693 0,686 0,679 0,686 0,671 0,671 0,665 0,669 0,89 
0,577 0,577 0,55 0,568 0,428 0,435 0,462 0,442 0,453 
0,237 0,244 0,264 0,248 0,251 0,25 0,258 0,253 0,310 
0,374 0,381 0,401 0,385 0,401 0,394 0,435 0,41 0,448 
0,718 0,725 0,725 0,723 0,739 0,745 0,739 0,741 0,903 
*RF= Rectusfemoris; VI= Vastusintermedius; EUS=expert ultrasonographer; PI= 
primary investigator; mean = instance 1; mean 2 = instance 2 
 
Table 2: Intra-rater and inter-rater reliability quadriceps echogenicity 
measurements 
Echogenicity measures 
RF EUS PI 1 PI 2 
 75 73 79 
 99 95 92 
 57 57 64 
 79 64 65 
 108 102 107 
VI 
 62 59 62 
 42 39 36 
 28 38 30 
 40 30 43 
 72 45 75 







Table 3: Intra-rater and inter-rater reliability of diaphragm thickness 
measurements 
Inspiration  
US 1 US 2 US 3 EUS: 
mean 
PI 1 PI 2 PI 3 PI: mean PI: mean 2 
0,356 0,341 0,371 0,356 0,249 0,223 0,238 0,236 0,126 
0,204 0,216 0,245 0,221 0,2 0,212 0,208 0,207 0,198 
0,516 0,269 0,294 0,360 0,282 0,282 0,274 0,280 0,432 
0,218 0,244 0,237 0,233 0,233 0,207 0,226 0,222 0,242 
0,344 0,344 0,37 0,353 0,237 0,226 0,248 0,237 0,201 
0,255 0,229 0,243 0,242 0,328 0,325 0,321 0,325 0,343 
0,277 0,299 0,325 0,300 0,314 0,31 0,310 0,311 0,364 
Expiration  
0,307 0,329 0,333 0,323 0,204 0,172 0,216 0,197 0,109 
0,171 0,197 0,178 0,182 0,171 0,186 0,178 0,178 0,168 
0,264 0,264 0,267 0,265 0,253 0,256 0,263 0,257 0,4 
0,189 0,207 0,196 0,198 0,192 0,207 0,196 0,199 0,212 
0,314 0,314 0,314 0,314 0,211 0,2 0,211 0,207 0,163 
0,192 0,195 0,221 0,203 0,277 0,270 0,255 0,267 0,311 
0,251 0,266 0,288 0,268 0,281 0,288 0,278 0,282 0,319 
*EUS=expert ultrasonographer; PI= primary investigator; mean = instance 1; mean 2 
= instance 2 
 
2. Peripheral and respiratory muscle strength testing 
Procedure: The PI scheduled one session with participants. At this session the aims 
and objectives for peripheral and respiratory muscle strength testing were again 
explained and informed consent obtained. Mouth pressure manometer measurements 
for diaphragmatic strength (see Section 3.11.1.3) and handheld dynamometry 
measurements for peripheral muscle strength (see Section 3.11.1.2) were completed. 
All baseline measurements (height, weight and age) were recorded (Refer to Table 4). 
 




Gender Age  Weight (kg) Height (m) 
1 female 24 66kg 1,7 
2 female 64 60kg 1,57 
3 female 26 66kg 1,68 
4 female 25 48kg 1,58 
5 female 61 64kg 1,64 
 
Intra-rater reliability: Handheld dynamometry and manometer measurements were 
performed by the PI on the same day separated by a fifteen-minute interval, using the 
same equipment with the participant seated. PI measurements were compared to 





Table 5: Intra-rater reliability of manometer measurements 
Instance 1 Instance 2 
MIP 1 MIP 2 MIP 3 Best MIP MIP1 MIP 2  MIP 3 Best MIP 
127 133 132 133 117 126 112 126 
52 47 47 52 52 48 49 52 
90 92 92 92 88 83 90 90 
78 75 72 78 73 70 65 73 
65 70 65 70 71 73 65 73 
MIP= maximal inspiratory pressure 
 
Table 6: Intra-rater reliability of handheld dynamometry measurements 
Instance 1 Left quadriceps Instance 2 Left quadriceps 
HHD 1 HHD 2 HHD 3 Best 
HHD 
HHD1 HHD 2  HHD 3 Best HHD 
208,6 206,8 219,3 219,3 208,2 189,9 191,3 208,2 
189 196,6 193,5 196,6 199,7 191,3 196,6 199,7 
160,6 147,7 143,2 160,6 144,1 167,7 153,4 167,7 
197,1 185,5 198,4 198,4 206,8 209,5 193,5 209,5 
223,3 220,6 222,4 223,3 225,1 229,1 223,7 229,1 
 
Instance 1 Right quadriceps Instance 2 Right quadriceps 
HHD 1 HHD 2 HHD 3 Best 
HHD 
HHD1 HHD 2  HHD 3 Best HHD 
228,6 212,2 214 228,6 190,8 198,8 208,6 208,2 
161,5 173 167,2 173 170,8 159,7 168,6 170,8 
150,8 165 156,6 165 172,6 203,3 189,5 203,3 
222,9 241,1 224,2 241,1 230,9 218,8 215,3 230,9 
207,7 207,3 200,6 207,7 224,6 208,6 226 226 
HHD= handheld dynamometry  
 
Data analysis: Intra Class Correlation for average measures with a 95% confidence 
interval (CI) was used to determine intra- and inter-rater reliability. An ICC value of 





The ICC for measures of RF muscle thickness and echogenicity was 0,97 (0,87 - 0,99) 
between the measures of the EUS and PI and an ICC of 0,95 (0,56 - 0,99) between 
average measures of the RF muscle by the PI. The ICC for measures of VI muscle 
thickness and echogenicity was 0,97 (0,88 - 0,99) between measures of the EUS and 
PI. An ICC of 0,96 (0,66 - 0,99) between average measures of the VI muscle by the 
PI.  
 
The ICC for inspiration was 0,80 (0,37-0,94) and an ICC of 0,80 (0,39-0,94) for 
expiration between the EUS and PI. For the PI the ICC for inspiration was 0,70 (-2,40-
0,96) and 0,74 (-0,68-0,96) for expiration. 
 
2. Peripheral and respiratory muscle strength testing 
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For MIP an ICC of 0,99 (0,99-1,00) was seen for the PI. The ICC of the R quadriceps 
was 0,83 (-0,95-0,98) and the ICC was 0,97 (0,76-0,99) for the L quadriceps. 
 
CONCLUSION 
Excellent intra- and inter- rater reliability was achieved for ultrasonography measures 
of the diaphragm and quadriceps (RF and VI muscles). Excellent intra-rater reliability 




ADDENDUM J : Abstract presented at CCNC 
 
Physical Function Outcomes of Privately Admitted Intensive Care Unit Patients at 
Hospital Discharge 
 
Authors & Affiliations: Pool. HA1, Lupton-Smith. A1, Hanekom. SD1 
 
1Division of Physiotherapy, Health and Rehab Sciences, Faculty of Medicine and 
Health Sciences, Stellenbosch University 
 
Background: Poor physical function following critical illness is a major contributor to 
morbidity in survivors. Physical function has not been described within the Private 
Health population in South Africa.  
Objective: To describe muscle strength, physical function and exercise capacity in 
critical illness survivors at intensive care unit (ICU) and hospital discharge.  
Materials and methods: Prospective observational cohort study was conducted in the 
ICU’s of a Private Hospital in the Western Cape.  
Results: Preliminary results of 16 participants (8 male) with a mean age of 68.19 years 
(SD 15.58) are presented. The mean severity of illness score (SAPS 3) was 59.13 (SD 
15.47). The median length of ventilation was 5.78 (IQR 3.93 – 9.67) days, mean total 
length of stay was 13.38 (SD 7.85) days in ICU and 19.06 (SD 11.1) days in hospital. 
Mean Medical Research Council sum score (MRC SS) was 47.82 (SD 8.13) at ICU 
discharge and median MRC SS of 53.00 (IQR 40 – 56) at hospital discharge. Walking 
distance (exercise capacity) was a median of 117 (IQR 87 – 120) meters. Mean 
physical function scores were 36.91 (SD 6.06) at ICU discharge and 41.80 (SD 5.47) 
at hospital discharge using the Chelsea Critical Care Assessment tool (CPAx). 
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